Inhibition of Dynamin Mediated Endocytosis by the Dynoles s Synthesis and Functional Activity of a Family of Indoles Timothy A . Hill , † Christopher P . Gordon , † Andrew B . McGeachie , ‡ Barbara Venn - Brown , † Luke R . Odell , † Ngoc Chau , ‡ Annie Quan , ‡ Anna Mariana , ‡ Jennette A . Sakoff , § Megan Chircop ( nee Fabbro ) , ‡ Phillip J . Robinson , ‡ and Adam McCluskey * , † Chemistry , School of En V ironmental and Life Sciences , The Uni V ersity of Newcastle , Uni V ersity Dri V e , Callaghan NSW 2308 , Australia , Cell Signaling Unit , Children’s Medical Research Institute , The Uni V ersity of Sydney , 214 Hawkesbury Road , Westmead NSW 2145 , Australia , Department of Medical Oncology , Cal V ary Mater Newcastle , Edith Street , Waratah NSW 2298 , Australia Recei V ed January 13 , 2009 Screening identiﬁed two bisindolylmaleimides as 100 µ M inhibitors of the GTPase activity of dynamin I . Focused library approaches allowed development of indole - based dynamin inhibitors called dynoles . 100 - Fold in vitro enhancement of potency was noted with the best inhibitor , 2 - cyano - 3 - ( 1 - ( 2 - ( dimethylamino ) - ethyl ) - 1 H - indol - 3 - yl ) - N - octylacrylamide ( dynole 34 - 2 ) , a 1 . 3 ( 0 . 3 µ M dynamin I inhibitor . Dynole 34 - 2 potently inhibited receptor mediated endocytosis ( RME ) internalization of Texas red - transferrin . The rank order of potency for a variety of dynole analogues on RME in U2OS cells matched their rank order for dynamin inhibition , suggesting that the mechanism of inhibition is via dynamin . Dynoles are the most active dynamin I inhibitors reported for in vitro or RME evaluations . Dynole 34 - 2 is 15 - fold more active than dynasore against dynamin I and 6 - fold more active against dynamin mediated RME ( IC 50 ∼ 15 µ M ; RME IC 50 ∼ 80 µ M ) . The dynoles represent a new series of tools to better probe endocytosis and dynamin - mediated trafﬁcking events in a variety of cells . Introduction Dynamin is a large GTPase that plays a crucial role in both synaptic vesicle endocytosis and receptor mediated endocytosis , SVE a and RME , respectively . 1 - 5 It catalyzes hydrolysis of GTP to GDP , causing assembled dynamin to undergo an expansion ( length ) and contraction ( width ) that results in the ﬁssion of clathrin coated vesicles from the membrane . This mechanism has multiple biological roles and facilitates the recycling of synaptic vesicles , 2 , 5 the internalization of hormones and nutri - ents , and it is also used as a cellular entry point for viruses , toxins , and symbiotic organisms . 6 Neurotoxins botulinum and tetanus inhibit transmitter release from synapses , causing two severe neuroparalytic diseases , tetanus and botulism . Their action is dependent on their internalization via endocytosis into nerve terminals . 7 Dynamin comprises three major isoforms : dynamin I ( neu - rons ) , dynamin II ( ubiquitous ) , and dynamin III ( neurons and testes ) . 3 , 4 Common to all are four domains , a GTPase ( required for vesicle ﬁssion ) , 3 , 8 pleckstrin homology ( PH ) ( targeting domain and potentially a GTPase inhibitory module ) , 4 a GTPase effector domain ( GED , which controls dynamin self - assembly into rings ) , 9 , 10 and a proline - rich domain ( PRD ) ( which interacts with proteins containing an Src homology 3 ( SH3 ) domain 3 , 4 and is the site for dynamin I and III phosphorylation in vivo ) . 11 , 12 All domains are potential sites for small molecule interventions in dissecting endocytosis and potential drug targets . Dynamin inhibitors have attracted widespread attention and have been used to study endocytosis and other aspects of membrane dynamics in a variety of cellular systems . 13 - 16 Small molecule inhibitors offer many distinct advantages over tradi - tional means of dynamin inhibition in cells by expression of dynamin GTPase mutants or by small interfering RNA - mediated dynamin knockdown , which cannot readily be used to study rapid cellular effects . Small molecule , cell - permeable inhibitors are able to rapidly block endocytosis in minutes and are frequently reversible . 17 , 18 There is now a small but expanding “palette” of drugs available to rapidly and reversibly block dynamin I by distinct mechanisms of action : the myristoyl trimethyl ammonium bromide ( MiTMAB ) , 18 , 19 Bis - tyrphostin ( Bis - T ) , 20 room temperature ionic liquid ( RTIL ) , 21 and dyna - sore 17 series of dynamin inhibitors , which are operating at different stages in its cycle of GTPase activity . For example , MiTMAB and octyl trimethyl ammonium bromide ( OcTMAB ) block dynamin recruitment to the cell membrane . 18 Results From Bisindolylmaleimides to Indoles s Simpliﬁcation Improves Dynamin GTPase Inhibition . A medicinal chemistry program requires a viable lead compound . Subsequent lead optimization should facilitate the development of a more selective , potent , and less toxic analogue . The most difﬁcult task is frequently the initial lead discovery . Most leads are derived from existing compound libraries , combinatorial librar - ies , or natural products . In the present study , we needed to identify a lead amenable to rapid synthetic development . Screening a number of compound libraries ( data not shown ) identiﬁed the structurally interesting bisindolylmaleimides ( BIMs ) 1 and 2 as ∼ 100 µ M potent inhibitors of the GTPase activity of dynamin I ( Figure 1 ) . Note that 1 and 2 are pseudosym - metrical . Enzyme kinetic studies that showed BIMs 1 and 2 * To whom correspondence should be addressed . Phone : + 61 249 216486 . Fax : + 61 249 215472 . E - mail : Adam . McCluskey @ newcastle . edu . au . † Chemistry , School of Environmental and Life Sciences , The University of Newcastle . ‡ Cell Signaling Unit , Children’s Medical Research Institute , The University of Sydney . § Department of Medical Oncology , Calvary Mater Newcastle . a Abbreviations : RME , receptor medicated endocytosis ; SVE , synaptic vesicle endocytosis ; GED , GTPase effector domain ; PRD , proline rich domain ; PH , Pleckstrin homology ; SH3 , Src Homology 3 ; MiTMAB , myristoyl trimethyl ammonium bromide ; OcTMAB , octyl trimethyl am - monium bromide ; Bis - T , bis - tyrphostin ; RTIL , room temperature ionic liquid ; BIM , bisindolylmaleimide ; PKC , protein kinase C ; PSA , polar surface area ; U2OS , human bone osteosarcoma epithelial cells . J . Med . Chem . 2009 , 52 , 3762 – 3773 3762 10 . 1021 / jm900036m CCC : $ 40 . 75  2009 American Chemical Society Published on Web 05 / 21 / 2009 were competitive with GTP , indicating they are competitive inhibitors at the GTPase domain . BIMs of this nature are known inhibitors of protein kinase C ( PKC ) and glycogen synthase kinase 3 . 22 , 23 Access to a crystal or molecular modeled structure of the target protein greatly facilitates rational inhibitor development . In this particular case , while there is an apo structure of the rat GTPase domain published , it is the lack of a ligand that renders this structure unsuitable for modeling , as the GTPase domain undergoes considerable structural change upon GTP binding and GDP release . 24 There are no reports of the full - length structure of dynamin I . There are a number of literature syntheses leading to compounds such as 1 , especially in regard to their reported inhibition of PKC . 25 However , because the goal for our study was to produce rapid access to focused compound libraries ( typically 12 - 24 compounds per iteration ) , 1 was viewed as too complex . 25 - 30 Accordingly , we aimed to identify a minimal pharmacophore that would allow rapid , focused analogue development . Our approach to the desired compound libraries is the application of a robust focused library approach in which we placed access to compounds above synthetic elegance . Initial effort commenced by targeting the bare indole while maintaining the dimethylamino moiety ( Figure 2 ) , as this was strongly indicated from previous dynamin inhibitors we developed . 20 , 21 Library 1 analogues were synthesized in a one - step procedure commencing with the treatment of ﬁve commercially available indoles ( 3 - 7 ) with NaH , and addition of either 2 - chloro - N , N - dimethylethanamine or 3 - chloro - N , N - dimethylpropanamine to give substituted indoles ( 8 - 17 ) in good to excellent yields ( Scheme 1 ) . Six members of Library 1 were moderate ( IC 50 > 100 e 300 µ M ) dynamin I GTPase inhibitors ( Table 1 ) . Analogues 16 and 17 possessed additional C3 - substituents and were the most active of this group at 131 ( 5 and 143 ( 7 µ M , respectively . Compounds 8 - 11 were also active but with IC 50 values of g 300 µ M . Only analogues containing an indole - N - alkyl - N ( CH 3 ) 2 moiety inhibited dynamin . Based on this , and in keeping with our focused library approach , two approaches for Library 2 analogues were considered ( Table 2 ) . Exploration of the available chemical space at C3 either via simple peptide coupling approaches ( - CO 2 H , 14 - 17 ) ; or via Knovenangel approaches ( - CHO ; 12 and 13 ) . Given our previous Knovenangel approaches , 20 , 28 - 30 Library 2 was developed using previously reported cyanoamides ( 18a - h ) ( Scheme 2 ) . 20 , 31 - 33 The introduction of simple chains had a marked effect on potency with C 6 alkyl chains substituted analogues 25 and 33 Figure 1 . Lead bisindolmaleimides displaying modest levels of dynamin inhibition . Figure 2 . BIM scaffold simpliﬁcation for rational design of dynamin inhibitors . Scheme 1 a a Reagents and conditions : ( i ) NaH , THF ; ( ii ) 2 - chloro - N , N - dimethyl - ethanamine or 3 - chloro - N , N - dimethylpropanamine . Table 1 . Library 1 : Inhibition of Dynamin I GTPase Activity by Substituted Indoles 8 - 17 a IC 50 determinations are the average of at least three separate experi - ments , each in duplicate . b ∼ 50 % Inhibition at 300 µ M drug concentrations , full IC 50 determination not conducted . c “ - ” No inhibition at 300 µ M drug concentration . Inhibition of Dynamin Mediated Endocytosis by the Dynoles Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 3763 returning IC 50 values of 7 . 69 and 6 . 62 µ M , respectively , and C 8 alkyl analogues 26 and 34 returned IC 50 values of 9 . 05 and 3 . 33 µ M , respectively , which were 10 - 30 times more potent than the original lead compounds . Replacement of the alkyl side chain with a benzyl moiety causes concomitant decrease in dynamin inhibition potency ( 27 , IC 50 ) 201 ( 15 µ M ) , presumably via a failure to engage a favorable hydrophobic binding interaction . Elongation of the alkyl side chains via synthesis of analogues with C 10 , C 12 , and C 14 alkyl chains ( 35 - 40 ) afforded no further potency enhancements . Despite this , all C 10 - C 14 analogues , 35 - 40 , returned inhibitory values better than the original lead compounds 1 and 2 ( Table 3 ) . This lack of improvement is not surprising , as entropic effects increase the disorder of the terminal chain . It is also possible that chain elongation begins to encroach upon a charged binding pocket , which would generate unfavorable hydrophobic - charged domain interactions and in turn encourage chain folding , preventing additional beneﬁcial interactions and hence any increase in activity . It is also of note that the N , N - dimethylaminopropyl - substituted C 10 , C 12 , and C 14 analogues ( 38 - 40 ) are uniformly less active than the corresponding N , N - dimethylaminoethyl analogues ( 35 - 37 ) , which suggests there is ﬁnite space available to accommodate both the indole nucleus and the long alkyl side chains and that the ultimate binding is a compromise of accommodating the pivotal N , N - dimethylamino moiety and the steric bulk of the alkyl chains . The importance of the terminal N , N - dimethylamino moiety at N1 was examined by the synthesis of analogues shown lacking this moiety ( 41 - 51 ) and analogue 52 , which lacks only the N , N - dimethylamino nitrogen atom of 34 - 1 ( IC 50 ) 3 . 33 ( 0 . 75 µ M ) in Table 3 . With these simple modiﬁcations , no changes that removed the N , N - dimethylamino moiety were tolerated , strongly suggesting that this is a key pharmacophoric unit for the inhibition of dynamin I by indoles of this nature . While analogue 34 displays an excellent level of dynamin I inhibition , it is also highly lipophilic with a calculated CLogP ) 5 . 01 , on the cusp of a Lipinski violation , 34 , 35 suggesting good cell penetration ( see below ) but poor aqueous solubility . With the exception of the initial series of analogues , we did not explore the role of the indole C2 - CH 3 substituent , but simple CLogP and polar surface area ( PSA ) calculations suggest that the removal of the C2 - CH 3 will install favorable properties with LogP and PSA calculated to be 4 . 81 and 43 . 3 Å 2 , respectively . Synthesis was conducted as described in Schemes 1 and 2 from indole 5 , affording the desired analogue ( Figure 3 ) . Removal of the C2 methyl group resulted ( 34 - 2 , Figure 3 ) in a 3 - fold increase in potency for dynamin I inhibition ( IC 50 ) 1 . 30 ( 0 . 30 µ M ) , now representing the most potent dynamin I inhibitor thus far , 2 times more potent than our existing Bis - T analogues and 15 × more potent than dynasore . 17 , 20 This increase in potency is most likely a result of reduced steric strain and greater ﬂexibility associated with the cyanoamide moiety and its ability to remain in the same plane as the indole nucleus . Removal of the C2 - CH 3 moiety decreases the dihedral angle Table 2 . Library 2 : Inhibition of Dynamin I GTPase Activity by Substituted Indoles 19 - 34 a IC 50 determinations are the average of at least three separate experi - ments , each in duplicate . b ∼ 50 % Inhibition at 300 µ M drug concentrations , full IC 50 determination not conducted . [ c ] “ - ” No inhibition at 300 µ M drug concentration . Scheme 2 . Library 2 a a Reagents and conditions : ( i ) piperidine ( cat ) , EtOH reﬂux , 3 h . 3764 Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 Hill et al . associated with the cyanoamide moiety from 41 . 69 ° to 0 . 84 ° , essentially coplanar with the indole nucleus . 36 In Vitro Inhibition of Dynamin Leads to a Complete Block in Receptor Mediated Endocytosis . Given that dynamin is essential for endocytosis , we felt it appropriate to determine the ability of our ﬁve most potent indoles , 26 , 33 , 34 - 1 , 34 - 2 , and 35 , to block RME in cells , and based on earlier efforts , we focused on human bone osteosarcoma epithelial ( U2OS ) cells . Using previously established approaches , we examined the effect of 26 , 33 , 34 - 1 , 34 - 2 , and 35 on the internalization of Texas Red - transferrin ( Tf - TxR ) , which binds to the transferrin receptor and is internalized by a dynamin II - dependent pathway . 18 After 8 min of internalization under control conditions ( DMSO treatment ) , the cells showed considerable endocytosis of Tf - TxR ( Figure 4 , top row ) in the periphery and perinuclear region of the cell , which is typical of Tf localization in early and recycling endosomes . 37 , 38 After a 30 min preincubation in the presence of 30 µ M of indoles 26 , 33 , 34 - 1 , and 35 or 10 µ M of 34 - 2 , RME was greatly reduced ( Figure 4 ) . It is clear from Figure 4 that 26 , 33 , 34 - 1 , 34 - 2 , and 35 differ in their ability to block RME , as evidenced by the very low , but observable , levels of Tf - TxR apparent ( red coloration at the periphery of the DAPI ( blue ) stained nucleus ) with 26 , 33 , and 35 . With 34 - 1 and 34 - 2 , we note the complete or near - complete lack of color associated with Tf - TxR uptake , representing a complete block of endocytosis . Tf - TxR internalization was completely blocked at 100 µ M by all ﬁve compounds ( data not shown ) . Importantly , cell morphology was unaffected by the drug treatment , even after 30 min exposure ( data not shown ) , indicating that there was no membrane disruption . To quantify the effect of 26 , 33 , 34 - 1 , 34 - 2 , and 35 in U2OS cells , we used our previously reported automated quantitative RME assay based on endocytosis of Tf - A594 . The IC 50 for inhibition of RME by 26 in U2OS cells was 13 . 2 ( 2 . 6 µ M ( Figure 5 ) , which compares favorably with its IC 50 for dynamin I inhibition in vitro , 9 . 05 ( 1 . 68 µ M . Identical trends were observed for indoles 33 , 34 - 1 , 34 - 2 , and 35 , returning IC 50 ( RME ) values of 14 . 3 ( 2 . 7 , 10 . 8 ( 1 . 4 , 5 . 0 ( 0 . 9 , and 58 . 2 ( 11 . 1 µ M versus IC 50 ( in vitro ) s 6 . 62 ( 1 . 52 , 3 . 33 ( 0 . 75 , 1 . 30 ( 0 . 30 , and 10 . 1 µ M , respectively . This rank order of potency for RME inhibition closely matches the rank order of potency for inhibition of dynamin’s GTPase activity , suggesting that the mechanism of inhibition is via dynamin . Indole 34 - 2 represents the most potent inhibitor of dynamin mediated RME yet reported and is 15 - fold more potent than dynasore in both dynamin in vitro and RME based assays . 17 To determine whether the dynoles are toxic to cells , we assessed the viability of ﬁve ﬁbroblast cell lines ( hTert - immortalized breast stromal ﬁbroblast , two primary skin ﬁbroblast lines , a primary myoblast cell line , and NIH3T3 mouse ﬁbroblasts ) following 7 days of continuous exposure to dynole 34 - 2 using the Trypan Blue exclusion assay . Membrane integrity was not affected because > 98 % of cells , in all ﬁve cell lines , remained viable in the presence of dynole 34 - 2 ( 10 µ M ) . Mechanism of Dynamin in Vitro Inhibition . Our RME studies clearly demonstrate that indoles 26 , 33 , 34 - 1 , 34 - 2 , and 35 are efﬁcient blockers of endocytosis , with the RME IC 50 values obtained following an identical trend for the in vitro Table 3 . Library 3 : Inhibition of Dynamin I GTPase Activity by Substituted Indoles 35 - 52 a IC 50 determinations are the average of at least three separate experi - ments , each in duplicate . b “ - ” No inhibition at 300 µ M drug concentration . Figure 3 . Chemical structures and dynamin IC 50 values for dynole 34 and the C2 demethyl dynole 34 . To emphasize the structural similarity with the parent indole 34 , we have renamed these compounds dynole 34 - 1 and 34 - 2 . Inhibition of Dynamin Mediated Endocytosis by the Dynoles Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 3765 inhibition of dynamin . Using traditional enzyme kinetics ( Figure 6 top , bottom ) , we found that indole 34 - 1 is uncompetitive with GTP . Conclusion Synthetically simple approaches facilitated the rational design of the most potent dynamin inhibitors reported thus far . Commencing with the simpliﬁcation of the bisindolylmaleimide leads , 1 and 2 , we designed and synthesized a series of small highly focused libraries exploring the structural requirements for inhibition of dynamin I GTPase . Modiﬁcations developed herein were restricted to synthetically simple approaches and afforded new inhibitors of dynamin I displaying potency 100 × that of the original lead compounds that we call the dynole series ( Dyn amin inhibition by ind oles ) . Our data clearly demonstrates efﬁcient block of endocytosis ( RME ) , and the rank order of potency ( of the dynoles ) in blocking endocytosis correlates well with their rank potency order for dynamin I inhibition . This suggests that the observed endocytosis block is via the inhibition of dynamin GTPase activity . Importantly , this potency is not conﬁned to the test tube with a complete endocytic block in cells being observed with dynoles 34 - 1 and 34 - 2 . These analogues display high cell permeability and efﬁciency with cellular IC 50 s less than an order of magnitude Figure 4 . Dynoles 26 , 33 , 34 - 1 , 34 - 2 , and 35 block internalization of Tf - TxR in U2OS cells . U2OS cells were preincubated with vehicle only or different dynoles for 30 min and then incubated with Tf - TxR ( A1 ) for 8 min at 37 ° C and acid washed and ﬁxed , and internalized Tf - TxR was detected by ﬂuorescence microscopy ( left column ) . Nuclei were stained blue with DAPI to show the position of the cells ( middle column ) . The combined image ( right column ) shows the position of the cell nucleus ( blue ) and the internalized Tf - TxR ( red ) . 3766 Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 Hill et al . of the in vitro data . In the presence of the lead dynole 34 - 2 , ﬁbroblast cells remained viable for 7 days in culture , indicating that the drug is not toxic to these cells . The mechanism of inhibition by dynole 34 - 1 was uncom - petitive . Uncompetitive inhibition is relatively unusual and can occur when an inhibitor only binds to the complex between the enzyme ( dynamin ) and substrate ( GTP ) . This indicates that the dynole binds to the enzyme - substrate complex at a site other than the active site , which might be an allosteric site within the GTPase domain that becomes available upon GTP binding to dynamin . Currently , dynasore is the primary inhibitor of dynamin mediated endocytosis in routine use . 17 The dynoles clearly display superior IC 50 values and their lipophilic nature facilitates membrane permeability , evidenced by the highly efﬁcient block of RME . These data correlate well with predicted physicochem - ical properties of dynole 34 - 2 with CLogP ) 4 . 81 , a polar surface area ( PSA ) ) 41 . 4 Å 2 , and a dipole of 5 . 93 debye versus CLogP ) 3 . 65 , PSA ) 89 . 0 Å 2 , and a dipole ) 6 . 63 debye for dynasore , suggesting a greater ease of cell penetration for the dynoles . 36 While not a pivotal consideration for the development of biochemical probes , the dynoles lack dynasores’ catechol moiety and have lower number of hydrogen bond donor and acceptor groups , rendering this new family of dynamin inhibitors amenable for therapeutic development . 35 We thus believe that the dynoles , in particular dynole 34 - 2 , with the synthetic ease of its access and its high dynamin I in vitro inhibition ( IC 50 ) 1 . 30 ( 0 . 30 µ M ) and excellent ability to inhibit RME ( IC 50 ) 5 . 0 ( 0 . 9 µ M ) represent a signiﬁcant advance for the study of dynamin mediated endocytosis and will be of considerable value to researchers in the ﬁeld . Experimental Section Biology . Materials . Phosphatidylserine ( PS ) , phenylmethylsul - fonylﬂuoride ( PMSF ) , and Tween 80 were from Sigma - Aldrich ( St . Louis , MO ) . GTP was from Roche Applied Science ( Germany ) , leupeptin was from Bachem ( Bubendorf , Switzerland ) . Gel elec - trophoresis reagents , equipment , and protein molecular weight markers were from Bio - Rad ( Hercules , CA ) . Collagenase was from Roche . Paraformaldehyde ( PFA ) was from Merck Pty Ltd . ( Kilsyth , Australia ) . Coverslips were from Lomb Scientiﬁc ( Sydney , Aus - tralia ) . Penicillin / streptomycin , phosphate buffered salts , fetal calf serum ( FCS ) , and Dulbecco’s minimal essential medium ( DMEM ) were from Invitrogen ( Mount Waverley , Victoria , Australia ) . Alexa - 594 conjugated Tf ( Tf - A594 ) and DAPI were from Molecular Probes ( Oregon ) . All other reagents were of analytical reagent grade or better . Drugs . Drugs were made in - house or were purchased from Sigma - Aldrich . The drugs were made up as stock solutions in 100 % DMSO and diluted in 50 % v / v DMSO / 20 mM Tris / HCl pH 7 . 4 or cell media prior to further dilution in the assay . The ﬁnal DMSO concentration in the GTPase or endocytosis assays was at most 3 . 3 % or 1 % , respectively . The GTPase assay for dynamin I was unaffected by DMSO up to 3 . 3 % . Drugs were dissolved as 30 mM stocks in 100 % DMSO and were light yellow in color . Stocks were stored at - 20 ° C for several months . They were diluted into solutions of 50 % DMSO made up in 20 mM Tris / HCl pH 7 . 4 and then diluted again into the ﬁnal assay . Protein Production . Dynamin I was puriﬁed from sheep brain by extraction from the peripheral membrane fraction of whole brain 39 and afﬁnity puriﬁcation on GST - Amph2 - SH3 - sepharose as described , 40 yielding 8 - 10 mg of protein from 250 g of sheep brain . Malachite Green GTPase assay . The malachite green method was used for the sensitive colorimetric detection of orthophosphate ( P i ) . It is based on the formation of a phosphomolybdate complex at low pH with basic dyes , causing a color change . The assay procedure is based on stimulation of native sheep brain - puriﬁed dynamin I by sonicated phosphatidylserine ( PS ) liposomes . 41 However , in our earlier studies , we used 200 nM dynamin I , while in the present study we used 20 nM , requiring a reformulation of assay volumes and the malachite green reagent for the present study . 19 , 20 , 41 Puriﬁed dynamin I ( 20 nM ) ( diluted in 6 mM Tris / HCl , 20 mM NaCl , 0 . 01 % Tween 80 , pH 7 . 4 ) was incubated in GTPase assay buffer ( 5 mM Tris / HCl , 10 mM NaCl , 2 mM Mg 2 + , 0 . 05 % Tween 80 , pH 7 . 4 , 1 µ g / mL leupeptin , and 0 . 1 mM PMSF ) and GTP 0 . 3 mM in the presence of test compound for 30 min at 37 ° C . The ﬁnal assay volume was 150 µ L in round - bottomed 96 - well plates . Plate incubations were performed in a dry heating block with shaking at 300 rpm ( Eppendorf Thermomixer ) . Dynamin I GTPase activity was maximally stimulated by addition of different concentrations of phosphatidylserine liposomes . This assay can also be conducted in the absence of Tween with little effect on the IC 50 values noted for the indoles listed in Figures 4 - 5 . The reaction was terminated with 10 µ L of 0 . 5 M EDTA pH 8 . 0 , and the samples were stable for several hours at room temperature . To each well was added 40 µ L of malachite green solution ( 2 % w / v ammonium molybdate tetrahydrate , 0 . 15 % w / v malachite green , and 4 M HCl : the solution was passed through 0 . 45 µ m ﬁlters and stored in the Figure 5 . IC 50 curves for endocytosis block in U2OS cells of dynoles 26 , 33 , 34 - 1 , 34 - 2 , and 35 . U2OS cells were preincubated with vehicle only or different dynoles for 30 min and then incubated with Tf - TxR ( A1 ) for 8 min . Data is mean ﬂuorescence as a percent of control cells ( triplicate determinations on approximately 1200 cells each ) ( SEM . The results are representative of three independent experiments . Figure 6 . Kinetic analysis of interactions of dynole 34 - 1 with dynamin GTPase . Data shows this dynole is uncompetitive with GTP . Inhibition of Dynamin Mediated Endocytosis by the Dynoles Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 3767 dark for up to 2 months at room temperature ) . Color was allowed to develop for 5 min ( and was stable up to 2 h ) , and the absorbance of samples in each plate was determined on a microplate spectro - photometer at 650 nm . Phosphate release was quantiﬁed by comparison with a standard curve of sodium dihydrogen ortho - phosphate monohydrate ( baked dry at 110 ° C overnight ) , which was run in each experiment . GraphPad Prism 5 ( GraphPad Software Inc . , San Diego , CA ) was used for plotting data points and analysis of enzyme kinetics using nonlinear regression . The curves were generated using the Michaelis - Menten equation V ) V max [ S ] / ( K m + [ S ] ) where S ) PS activator or GTP substrate . After the V max and K m values were determined , the data was transformed using the Lineweaver - Burke eq 1 / V ) 1 / V max + ( K m / V max ) ( 1 / [ S ] ) . Texas Red - Tfn Uptake . U2OS cells were cultured in DMEM supplemented with 10 % FCS at 37 ° C and in 5 % CO 2 in a humidiﬁed incubator . Tf uptake was analyzed based on methods previously described . 41 Brieﬂy , cells were grown in ﬁbronectin - coated ( 5 µ g / mL ) 96 - well plates . The cells were serum - starved overnight ( 16 h ) in DMEM minus FCS . Cells were then incubated with indoles 26 , 33 , 34 - 1 , 34 - 2 , and 35 ( usually 30 µ M ) or vehicle for 30 min prior to addition of 4 µ g / mL of Tf - TxR for 8 min at 37 ° C . Cell surface - bound Tf was removed by incubating the cells in an ice - cold acid wash solution ( 0 . 2 M acetic acid + 0 . 5 M NaCl , pH 2 . 8 ) for 10 min and was rinsed with ice - cold PBS for 5 min . Cells were immediately ﬁxed with 4 % PFA for 10 min at 37 ° C . Nuclei were stained using DAPI . Quantitative analysis of the inhibition of Tf - TxR endocytosis in U2OS cells was performed on large numbers of cells by an automated acquisition and analysis system ( Image Xpress Micro , Molecular Devices , Sunnyvale , CA ) . Nine images were collected from each well , averaging 40 - 50 cells per image . The average integrated intensity of Tf - TxR signal per cell was calculated for each well using IXM system and the data expressed as a percentage of control cells ( vehicle treated ) . The average number of cells for each data point was ∼ 1200 . IC 50 values were calculated using Graphpad Prism v5 , and data was expressed as mean ( 95 % conﬁdence interval ( CI ) for 3 wells and ∼ 1200 cells . Cell Viability Assay . Cell viability and membrane integrity was assessed by the Trypan Blue exclusion assay . Cells were seeded into 10 cm dish at a density of 1 × 10 5 cells per dish . On day 0 ( 24 h after seeding ) , cells were treated in the presence and absence of dynole 34 - 2 or vehicle control ( 0 . 5 % DMSO ) for 7 days . Cells ( ﬂoating and adherent ) were collected and cell viability was measured by Vi - CELL XR cell viability analyzer 2 . 03 ( Beckman Coulter ) . Chemistry . General Methods . THF was freshly distilled from sodium - benzophenone . Flash chromatography was carried out using silica gel 200 - 400 mesh ( 60 Å ) . 1 H and 13 C NMR were recorded at 300 and 75 MHz , respectively , using a Bruker Avance 300 MHz spectrometer in CDCl 3 and DMSO - d 6 . GCMS was performed using a Shimadzu GCMS - QP2100 . The instrument uses a quadrupole mass spectrometer and detects samples via electron impact ionization ( EI ) . The University of Wollongong , Australia , Biomolecular Mass Spectrometry Laboratory , analyzed samples for HRMS . The spectra were run on the VG Autospec - oa - tof tandem high resolution mass spectrometer using CI ( chemical ionization ) , with methane as the carrier gas and PFK ( perﬂuorokerosene ) as the reference . Microanalysis was conducted at the Microanalyis Unit at the Australian National University , Canberra , Australia . All samples returned satisfactory analyses . ( 2 - Indol - 1 - ylethyl ) dimethylamine ( 8 ) . To a cooled solution ( 0 ° C ) of indole ( 3 ) ( 3 . 0 g , 25 . 6 mmol ) and THF ( 50 mL ) was added slowly NaH ( 50 % dispersion in mineral oil ) ( 2 . 0 g , 41 . 7 mmol ) . This solution was allowed to stir for 30 min , then N , N - dimethy - lamino - 2 - chloroethane ( 3 . 2 g , 29 . 75 mmol ) was added and the solution was heated at reﬂux for 70 h . Solution was allowed to cool and water added ( 50 mL ) . The organic layer was removed , and the aqueous layer extracted with ethyl acetate ( 2 × 50 mL ) . Combined organic layers were dried ( MgSO 4 ) and evaporated under reduced pressure , giving orange oil . This was puriﬁed via short column chromatography DCM : MeOH ( 90 : 10 ) . Combination of the desired fractions and concentration under reduced pressure gave the desired product as a yellow oil , 3 . 50 g ( 70 % ) . 1 H NMR ( CDCl 3 ) δ 7 . 71 ( dd , J ) 8 . 5 Hz , 1 . 0 Hz , 1H ) , 7 . 43 ( d , J ) 8 . 4 Hz , 1H ) , 7 . 30 ( dt , J ) 7 . 0 Hz , 1 . 0 Hz , 1H ) , 7 . 17 ( m , 2H ) , 6 . 55 ( d , J ) 3 . 5 Hz , 1H ) , 4 . 25 ( t , J ) 7 . 0 Hz , 2H ) , 2 . 64 ( t , J ) 7 . 0 Hz , 2H ) , 2 . 26 ( s , 6H ) . 13 C NMR ( CDCl 3 ) δ 135 . 7 , 128 . 0 , 127 . 3 , 121 . 0 , 120 . 3 , 119 . 1 , 109 . 1 , 100 . 4 , 56 . 0 , 44 . 9 , 43 . 8 . ( 3 - Indol - 1 - ylpropyl ) dimethylamine ( 9 ) . Compound 9 was prepared in a similar manner to the synthesis of 8 , from indole ( 3 ) and 3 - chloro - N , N - dimethylpropanamine , to give a yellow oil in a 68 % yield . 1 H NMR ( CDCl 3 ) δ 7 . 72 ( dd , J ) 8 . 4 Hz , 0 . 6 Hz , 1H ) , 7 . 43 ( d , J ) 8 . 4 Hz , 1H ) , 7 . 28 ( dt , J ) 7 . 0 Hz , 1 . 1 Hz , 1H ) , 7 . 17 ( m , 2H ) , 6 . 56 ( d , J ) 3 . 1 Hz , 1H ) , 4 . 24 ( t , J ) 6 . 9 Hz , 2H ) , 2 . 31 ( t , J ) 7 . 0 Hz , 2H ) , 2 . 26 ( s , 6H ) , 2 . 00 ( quin , J ) 6 . 9 Hz , 2H ) . 13 C NMR ( CDCl 3 ) δ 135 . 6 , 128 . 1 , 127 . 4 , 120 . 9 , 120 . 4 , 118 . 7 , 108 . 9 , 100 . 5 , 55 . 9 , 44 . 9 , 43 . 5 , 27 . 7 . Dimethyl - [ 2 - ( 2 - methylindol - 1 - yl ) ethyl ] amine ( 10 ) . Compound 10 was prepared in a similar manner to the synthesis of 8 , from 2 - methylindole ( 4 ) and 3 - chloro - N , N - dimethylethanamine , to give a yellow oil in a 75 % yield . 1 H NMR ( CDCl 3 ) δ 7 . 45 ( d , J ) 7 . 8 Hz , 1H ) , 7 . 37 ( d , J ) 8 . 2 Hz , 1H ) , 7 . 10 ( m , 2H ) , 7 . 00 ( dt , J ) 7 . 8 Hz , 0 . 9 Hz , 1H ) , 4 . 15 ( t , J ) 6 . 7 Hz , 2H ) , 2 . 56 ( t , J ) 6 . 7 Hz , 2H ) , 2 . 22 ( s , 3H ) , 2 . 17 ( s , 6H ) . 13 C NMR ( 75 MHz , CDCl 3 ) δ 135 . 9 , 128 . 1 , 126 . 2 , 120 . 8 , 118 . 4 , 118 . 0 , 109 . 3 , 108 . 6 , 58 . 6 , 45 . 1 , 43 . 2 , 9 . 3 . Dimethyl - [ 3 - ( 2 - methylindol - 1 - yl ) propyl ] amine ( 11 ) . Com - pound 11 was prepared in a similar manner to the synthesis of 8 , from 2 - methylindole ( 4 ) and 3 - chloro - N , N - dimethylpropanamine , to give a yellow oil in a 73 % yield . 1 H NMR ( CDCl 3 ) δ 7 . 47 ( d , J ) 7 . 8 Hz , 1H ) , 7 . 35 ( d , J ) 8 . 2 , 1H ) , 7 . 10 ( m , 2H ) , 7 . 00 ( dt , J ) 7 . 8 Hz , 1 . 1 Hz , 1H ) , 4 . 10 ( t , J ) 7 . 8 Hz , 2H ) , 3 . 35 ( t , J ) 6 . 9 Hz , 2H ) , 2 . 37 ( s , 3H ) , 2 . 13 ( t , J ) 6 . 9 Hz , 2H ) , 2 . 09 ( s , 6H ) , 1 . 80 ( quin , J ) 6 . 9 Hz , 2H ) . 13 C NMR ( CDCl 3 ) δ 135 . 9 , 128 . 1 , 126 . 0 , 120 . 8 , 118 . 4 , 117 . 9 , 110 . 2 , 108 . 6 , 55 . 6 , 45 . 0 , 42 . 7 , 27 . 8 , 9 . 3 . 1 - ( 2 - Dimethylaminoethyl ) - 2 - methyl - 1 H - indole - 3 - carbalde - hyde ( 12 ) . Compound 12 was prepared in a similar manner to the synthesis of 8 , from 2 - methylindole - 3 - carboxaldehyde ( 5 ) and 2 - chloro - N , N - dimethylethanamine , to give , after recrystallization from ethanol , a white solid in a 78 % yield ; mp 50 - 52 ° C . 1 H NMR ( CDCl 3 ) δ 10 . 25 ( s , 1H ) , 8 . 14 ( d , J ) 8 . 1 Hz , 1H ) , 7 . 43 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 24 ( m , 2H ) , 4 . 29 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 72 ( s , 3H ) , 2 . 62 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 29 ( s , 6H ) . 13 C NMR ( CDCl 3 ) δ 184 . 4 , 148 . 6 , 136 . 0 , 125 . 2 , 122 . 4 , 121 . 9 , 119 . 9 , 113 . 1 108 . 9 , 55 . 7 , 43 . 9 , 40 . 4 , 8 . 38 . 1 - ( 3 - Dimethylaminopropyl ) - 2 - methyl - 1 H - indole - 3 - carbalde - hyde ( 13 ) . Compound 13 was prepared in a similar manner to the synthesis of 8 , from 2 - methylindole - 3 - carboxaldehyde ( 5 ) and 2 - chloro - N , N - dimethylpropanamine , to give , after recrystallization from ethanol , an off - white solid in a 76 % yield ; mp 62 - 64 ° C . 1 H NMR ( CDCl 3 ) δ 10 . 08 ( s , 1H ) , 8 . 10 ( d , J ) 6 . 6 Hz , 1H ) , 7 . 5 ( d , J ) 7 . 2 Hz , 1H ) , 7 . 20 ( m , 2H ) , 4 . 2 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 70 ( s , 3H ) , 2 . 19 ( t , J ) 6 . 6 Hz , 2H ) , 2 . 12 ( s , 6H ) , 1 . 83 ( quin , J ) 6 . 9 Hz , 2H ) . 13 C NMR ( CDCl 3 ) δ 184 . 1 , 148 . 7 , 136 . 1 , 125 . 1 , 122 . 6 , 122 . 1 , 120 . 0 , 113 . 4 , 110 . 2 , 55 . 6 , 44 . 9 , 40 . 6 , 26 . 8 , 9 . 72 . [ 1 - ( 2 - Dimethylaminoethyl ) - 1 H - indol - 3 - yl ] acetic Acid ( 14 ) . Com - pound 12 was prepared in a similar manner to the synthesis of 8 , from 2 - methyl - 1 H - indole - 3 - carboxylic acid ( 6 ) and 2 - chloro - N , N - dimethylethanamine , to give , after recrystallization from ethanol , a white solid in a 82 % yield ; mp 54 - 56 ° C . 1 H NMR ( CDCl 3 ) δ 8 . 75 ( br , 1H ) , 7 . 61 ( d , J ) 7 . 8 Hz , 1H ) 7 . 30 ( d , J ) 7 . 9 Hz , 1H ) , 7 . 11 ( m , 3H ) , 4 . 18 ( t , J ) 7 . 1 Hz , 2H ) , 3 . 83 ( s , 2H ) , 2 . 38 ( t , J ) 7 . 1 Hz , 2H ) , 2 . 18 ( s , 6H ) . 13 C NMR ( 75 MHz , CDCl 3 ) δ 171 . 6 , 135 . 5 , 126 . 6 , 122 . 5 , 121 . 4 , 119 . 0 , 118 . 3 , 110 . 7 , 107 . 7 , 62 . 6 , 55 . 5 , 44 . 7 , 30 . 1 . [ 1 - ( 3 - Dimethylaminopropyl ) - 1 H - indol - 3 - yl ] acetic Acid ( 15 ) . Compound 15 was prepared in a similar manner to the synthesis of 8 , from 2 - methyl - 1 H - indole - 3 - carboxylic acid ( 6 ) and 2 - chloro - N , N - dimethylpropanamine , to give , after recrystallization from ethanol , a white solid in a 84 % yield ; mp 56 - 58 ° C . 1 H NMR ( 300 MHz , CDCl 3 ) δ 8 . 71 ( br , 1H ) , 7 . 62 ( d , J ) 7 . 6 Hz , 1H ) 7 . 30 ( d , J ) 7 . 9 Hz , 1H ) , 7 . 10 ( m , 3H ) , 4 . 16 ( t , J ) 6 . 4 Hz , 2H ) , 3 . 8 ( s , 3768 Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 Hill et al . 2H ) , 2 . 28 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 18 ( s , 6H ) , 1 . 80 ( quin , J ) 6 . 5 Hz , 2H ) . 13 C NMR ( CDCl 3 ) δ 171 . 7 , 135 . 7 , 126 . 7 , 122 . 7 , 121 . 5 , 118 . 9 , 118 . 3 , 110 . 7 , 107 . 7 , 62 . 6 , 55 . 5 , 44 . 7 , 30 . 9 , 26 . 3 . 3 - [ 1 - ( 2 - Dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] propi - onic Acid ( 16 ) . Compound 16 was prepared in a similar manner to the synthesis of 8 , from 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) propanoic acid ( 7 ) and 2 - chloro - N , N - dimethylethanamine , to give , after recrystallization from ethanol , a white solid in a 54 % yield ; mp 68 - 70 ° C . 1 H NMR ( CDCl 3 ) δ 10 . 60 ( br , 1H ) , 7 . 48 ( d , J ) 7 . 9 Hz , 1H ) , 7 . 31 ( d , J ) 8 . 1 Hz , 1H ) , 7 . 08 ( m , 2H ) , 6 . 96 ( dt , J ) 7 . 0 , 1 . 1 Hz , 1H ) , 4 . 01 ( t , J ) 5 . 9 Hz , 2H ) , 2 . 69 ( t , J ) 7 . 4 Hz , 2H ) , 2 . 43 ( t , J ) 5 . 8 Hz , 2H ) , 2 . 32 ( t , J ) 7 . 3 Hz , 2H ) , 2 . 14 ( s , 6H ) , 2 . 07 ( s , 3H ) 1 . 88 ( quin , J ) 7 . 4 Hz , 2H ) . 13 C NMR ( CDCl 3 ) δ 172 . 7 , 136 . 2 , 127 . 0 , 122 . 3 , 120 . 7 , 118 . 1 , 118 . 0 , 113 . 6 , 111 . 2 , 61 . 4 , 57 . 2 , 45 . 2 , 33 . 2 , 25 . 3 , 23 . 9 . 3 - ( 1 - ( 3 - Dimethylaminopropyl ) - 2 - methyl - 1 H - indol - 3 - yl ) pro - panoic Acid ( 17 ) . Compound 17 was prepared in a similar manner to the synthesis of 8 from 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) propanoic acid ( 7 ) and 3 - chloro - N , N - dimethylpropanamine , to give , after recrys - tallization from ethanol , a white solid in a 60 % yield ; mp 74 - 76 ° C . 1 H NMR ( CDCl 3 ) δ 10 . 61 ( br , 1H ) , 7 . 50 ( d , J ) 7 . 9 Hz , 1H ) , 7 . 31 ( d , J ) 8 . 1 Hz , 1H ) , 7 . 10 ( m , 2H ) , 6 . 95 ( dt , J ) 7 . 1 , 1 . 5 Hz , 1H ) , 4 . 01 ( t , J ) 5 . 9 Hz , 2H ) , 2 . 69 ( t , J ) 7 . 4 Hz , 2H ) , 2 . 38 ( t , J ) 5 . 8 Hz , 2H ) , 2 . 31 ( t , J ) 7 . 3 Hz , 2H ) , 2 . 14 ( s , 6H ) , 2 . 07 ( s , 3H ) 1 . 88 ( quin , J ) 7 . 4 Hz , 2H ) , 1 . 80 ( quin , J ) 5 . 8 Hz , 2H ) . 13 C NMR ( CDCl 3 ) δ 173 . 0 , 137 . 2 , 128 . 0 , 122 . 7 , 120 . 9 , 118 . 3 , 118 . 0 , 113 . 9 , 112 . 3 , 61 . 5 , 57 . 5 , 46 . 1 , 33 . 1 , 25 . 2 , 23 . 9 , 22 . 8 . N - Benzyl - 2 - cyano - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] acrylamide ( 19 ) . 1 - ( 2 - Dimethylaminoethyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 12 ) ( 0 . 2 g , 0 . 87 mmol ) , N - benzyl - 2 - cyanoacetamide ( 18a ) ( 0 . 15 g , 0 . 87 mmol ) , ethanol ( 5 mL ) , and piperidine were reﬂuxed for 3 h . After this time , water ( 30 mL ) was added to solution . This was then extracted with ethyl acetate ( 2 × 50 mL ) . Organic layers were combined , dried over MgSO 4 , and concentrated under reduced pressure , giving an orange solid . This was recrystallized from MeOH giving an orange solid ( 82 % ) ; mp 146 - 148 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 68 ( t , J ) 5 . 4 Hz , 1H ) , 8 . 38 ( s , 1H ) , 7 . 97 ( d , J ) 7 . 1 Hz , 1H ) , 7 . 55 ( d , J ) 7 . 1 Hz , 1H ) , 7 . 12 ( m , 8H ) , 4 . 42 ( d , J ) 4 . 3 Hz , 2H ) , 4 . 32 ( t , J ) 4 . 5 Hz , 2H ) , 2 . 58 ( m , 5H ) , 2 . 19 ( s , 6H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 4 , 146 . 1 , 144 . 6 , 139 . 4 , 136 . 9 , 128 . 2 , 127 . 3 , 126 . 7 , 124 . 5 , 122 . 4 , 121 . 2 , 121 . 0 118 . 3 , 110 . 5 , 107 . 6 , 98 . 2 , 57 . 9 , 45 . 5 , 41 . 1 , 40 . 6 , 11 . 2 . 2 - Cyano - N - ( 4 - methoxybenzyl ) - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 20 ) . Compound 20 was prepared in a similar manner to the synthesis of 19 , substituting N - ( 4 - methoxybenzyl ) - 2 - cyanoacetamide ( 18b ) for N - benzyl - 2 - cy - anoacetamide ( 18a ) to give , after recrystallization from methanol , an orange solid ( 47 % ) ; mp 165 - 167 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 33 ( s , 1H ) , 8 . 07 ( br , 1H ) , 7 . 96 ( m , 3H ) , 7 . 57 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 22 ( m , 2H ) , 7 . 12 ( d , J ) 8 . 7 Hz , 2H ) , 4 . 29 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 84 ( s , 3H ) , 2 . 72 ( s , 3H ) , 2 . 62 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 29 ( s , 6H ) . 13 C NMR ( 75 MHz , DMSO - d 6 ) δ 162 . 4 , 150 . 5 , 145 . 5 , 144 . 3 , 136 . 1 , 132 . 8 , 125 . 2 , 124 . 8 , 122 . 3 , 121 . 1 , 120 . 7 , 118 . 7 , 114 . 2 , 111 . 6 , 107 . 6 , 97 . 6 , 58 . 1 , 55 . 7 , 43 . 9 , 40 . 4 , 11 . 4 , 8 . 38 . 2 - Cyano - N - cyclohexyl - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] acrylamide ( 21 ) . Compound 21 was prepared in a similar manner to the synthesis of 21 , substituting N - cyclohexyl - 2 - cyanoacetamide ( 18c ) for N - benzyl - 2 - cyanoacetamide ( 18a ) to give , after recrystallization from methanol , a yellow solid ( 76 % ) ; mp 150 - 152 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 35 ( s , 1H ) , 8 . 07 ( br , 1H ) , 7 . 95 ( d , J ) 7 . 3 Hz , 1H ) , 7 . 60 ( d , J ) 7 . 3 Hz , 1H ) , 7 . 21 ( m , 2H ) , 4 . 28 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 71 ( m , 1H ) , 2 . 75 ( s , 3H ) , 2 . 60 ( t , J ) 7 . 1 Hz , 2H ) , 2 . 31 ( s , 6H ) , 1 . 91 ( m , 2H ) , 1 . 35 ( m , 2H ) , 1 . 20 - 1 . 15 ( m , 4H ) . 13 C NMR ( 75 MHz , DMSO - d 6 ) δ 162 . 4 , 145 . 6 , 144 . 1 , 137 . 5 , 125 . 5 , 122 . 1 121 . 1 , 120 . 9 , 118 . 1 , 110 . 3 , 108 . 2 , 98 . 4 , 55 . 6 , 48 . 9 , 43 . 8 , 40 . 3 , 25 . 5 , 24 . 3 , 24 . 1 , 10 . 9 . 2 - Cyano - N - ethyl - 3 - [ 1 ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - in - dol - 3 - yl ] acrylamide ( 22 ) . Compound 22 was prepared in a similar manner to the synthesis of 19 , substituting N - ethyl - 2 - cyanoaceta - mide ( 18d ) for N - benzyl - 2 - cyanoacetamide ( 18a ) to give , after recrystallization from ethanol , a yellow solid ( 58 % ) ; mp 135 - 137 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 33 ( s , 1H ) , 8 . 07 ( br , 1H ) , 7 . 96 ( d , J ) 7 . 2 Hz , 1H ) , 7 . 57 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 22 ( m , 2H ) , 4 . 29 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 24 ( quin , J ) 6 . 6 Hz , 2H ) , 2 . 72 ( s , 3H ) , 2 . 62 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 29 ( s , 6H ) , 1 . 14 ( t , J ) 7 . 3 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 2 , 145 . 5 , 144 . 2 , 136 . 8 , 124 . 5 , 122 . 4 , 121 . 1 , 120 . 9 , 118 . 3 , 110 . 4 , 107 . 5 , 98 . 9 , 55 . 7 , 34 . 7 , 43 . 9 , 40 . 4 , 13 . 6 , 10 . 4 . 2 - Cyano - N - propyl - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] acrylamide ( 23 ) . Compound 23 was prepared in a similar manner to the synthesis of 19 , substituting N - propyl - 2 - cyanoacetamide ( 18e ) for N - benzyl - 2 - cyanoacetamide ( 18a ) to give , after recrystallization from ethanol , a yellow solid ( 54 % ) ; mp 136 - 138 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 08 ( s , 1H ) , 7 . 85 ( br , 1H ) , 7 . 74 ( d , J ) 6 . 9 Hz , 1H ) , 7 . 37 ( d , J ) 6 . 8 Hz , 1H ) , 7 . 07 ( m , 2H ) , 4 . 49 ( t , J ) 5 . 6 Hz , 2H ) , 3 . 49 ( q , J ) 5 . 8 Hz , 2H ) , 2 . 94 ( s , 3H ) , 2 . 85 ( t , J ) 5 . 6 Hz , 2H ) , 2 . 60 ( s , 6H ) , 1 . 99 ( quin , J ) 6 . 4 Hz , 2H ) 1 . 42 ( t , J ) 6 . 5 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 2 , 145 . 5 , 144 . 2 , 136 . 8 , 124 . 5 , 122 . 4 , 121 . 1 , 120 . 9 , 118 . 3 , 110 . 4 , 107 . 5 , 98 . 9 , 57 . 9 , 45 . 4 , 41 . 7 , 41 . 3 , 22 . 2 , 11 . 4 , 11 . 3 . 2 - Cyano - N - butyl - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] acrylamide ( 24 ) . Compound 24 was prepared in a similar manner to the synthesis of 19 , substituting N - butyl - 2 - cyanoacetamide ( 18f ) for N - benzyl - 2 - cyanoacetamide ( 18a ) to give , after recrystallization from ethyl acetate , a yellow solid ( 54 % ) ; mp 137 - 139 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 33 ( s , 1H ) , 8 . 07 ( br , 1H ) , 7 . 96 ( d , J ) 7 . 2 Hz , 1H ) , 7 . 57 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 22 ( m , 2H ) , 4 . 29 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 22 ( q , J ) 6 . 9 Hz , 2H ) 2 . 72 ( s , 3H ) , 2 . 62 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 29 ( s , 6H ) , 1 . 48 ( quin , J ) 7 . 2 Hz , 2H ) , 1 . 33 ( sept , J ) 7 . 9 Hz , 2H ) , 0 . 89 ( t , J ) 7 . 2 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 2 , 145 . 5 , 144 . 2 , 136 . 8 , 124 . 5 , 122 . 4 , 121 . 1 , 120 . 9 , 118 . 3 , 110 . 4 , 107 . 5 , 98 . 9 , 55 . 7 , 43 . 9 , 40 . 4 , 39 . 5 , 25 . 4 , 19 . 4 , 13 . 0 , 12 . 2 . 2 - Cyano - N - hexyl - 3 - [ 1 ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - in - dol - 3 - yl ] - acrylamide ( 25 ) . Compound 25 was prepared in a similar manner to the synthesis of 19 , substituting N - hexyl - 2 - cyanoaceta - mide ( 18g ) for N - benzyl - 2 - cyanoacetamide ( 18a ) to give , after recrystallization from ethyl acetate , a yellow solid ( 67 % ) ; mp 119 - 121 ° C . 1 H NMR ( 300 MHz , DMSO - d 6 ) δ 8 . 25 ( s , 1H ) , 8 . 10 ( br , 1H ) , 8 . 00 ( d , J ) 7 . 1 Hz , 1H ) , 7 . 62 ( d , J ) 7 . 1 Hz , 1H ) , 7 . 20 ( m , 2H ) , 4 . 32 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 22 ( q , J ) 7 . 2 Hz , 2H ) , 2 . 70 ( s , 3H ) , 2 . 59 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 30 ( s , 6H ) , 1 . 46 ( quin , J ) 7 . 3 Hz , 2H ) , 1 . 27 ( m , 6H ) , 0 . 85 ( t , J ) 6 . 5 Hz , 2H ) ; 13 C NMR ( 75 MHz , DMSO - d 6 ) δ 163 . 1 , 145 . 2 , 144 . 2 , 136 . 2 , 125 . 0 , 122 . 3 , 120 . 9 , 19 . 9 , 118 . 2 , 110 . 4 , 106 . 5 , 99 . 0 , 55 . 8 , 44 . 1 , 40 . 2 , 38 . 7 , 28 . 6 , 25 . 8 , 25 . 2 , 21 . 7 , 11 . 3 . 2 - Cyano - N - octyl - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acyrlamide ( 26 ) . Compound 26 was prepared in a similar manner to the synthesis of 19 , substituting N - octyl - 2 - cyanoacetamide ( 18f ) for N - benzyl - 2 - cyanoacetamide ( 18a ) to give , after recrystallization from ethyl acetate , a yellow solid ( 56 % ) ; mp 112 - 113 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 30 ( s , 1H ) , 8 . 10 ( br , 1H ) , 7 . 99 ( d , J ) 7 . 0 Hz , 1H ) , 7 . 59 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 20 ( m , 2H ) , 4 . 28 ( t , J ) 7 . 1 Hz , 2H ) , 3 . 27 ( q , J ) 6 . 4 Hz , 2H ) , 2 . 74 ( s , 3H ) , 2 . 62 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 30 ( s , 6H ) , 1 . 50 ( quin , J ) 6 . 7 Hz , 2H ) , 1 . 31 ( m , 12H ) , 0 . 92 ( t , J ) 6 . 3 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 1 , 144 . 2 , 143 . 6 , 1363 , 125 . 5 , 123 . 3 , 121 . 0 , 120 . 4 , 118 . 3 , 110 . 2 , 107 . 4 , 99 . 0 , 56 . 7 , 44 . 3 , 41 . 4 , 40 . 2 , 28 . 9 , 28 . 5 , 26 . 1 , 25 . 4 , 22 . 1 , 12 . 4 . 2 - Cyano - N - benzyl - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2methyl - 1 H - indol - 3 - yl ] - acrylamide ( 27 ) . Compound 27 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylamino - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - benzyl - 2 - cyanoacetamide ( 18a ) to give , after recrystallization from ethanol , an orange solid ( 64 % ) ; mp 165 - 168 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 58 ( t , J ) 5 . 4 Hz , 1H ) , 8 . 28 ( s , 1H ) , 7 . 95 ( d , J ) 7 . 0 Hz , 1H ) , 7 . 64 ( d , J ) 7 . 1 Hz , 1H ) , 7 . 13 - 7 . 10 ( m , 8H ) , 4 . 54 ( d , J ) 4 . 4 Hz , 2H ) , 4 . 20 ( t , J ) 7 . 0 Hz , 2H ) , 2 . 72 ( s , 3H ) , 2 . 17 ( t , J ) 6 . 9 Hz , 2H ) , 2 . 10 ( s , 6H ) , 1 . 82 ( quin , J ) 6 . 9 Hz , 2H ) . 13 C NMR ( DMSO - d 6 ) δ 163 . 2 , 146 . 3 , 145 . 0 , 140 . 4 , 137 . 3 , 128 . 1 , 126 . 9 , 126 . 5 , 124 . 5 , 122 . 3 , 121 . 2 , 120 . 8 118 . 2 , 110 . 4 , 108 . 0 , 98 . 1 , 54 . 3 , 44 . 6 , 40 . 6 , 26 . 8 , 9 . 9 . Inhibition of Dynamin Mediated Endocytosis by the Dynoles Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 3769 2 - Cyano - N - ( 4 - methoxybenzyl ) - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 28 ) . Compound 28 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylaminopropyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and ( 4 - methoxybenzyl ) - 2 - cyanoacetamide ( 18b ) to give , after recrys - tallization from ethanol , a yellow solid ( 74 % ) ; mp 179 - 180 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 38 ( s , 1H ) , 8 . 11 ( br , 1H ) , 7 . 94 ( m , 3H ) , 7 . 55 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 22 ( m , 2H ) , 7 . 11 ( d , J ) 8 . 5 Hz , 2H ) , 4 . 25 ( t , J ) 7 . 5 Hz , 2H ) , 2 . 73 ( s , 3H ) , 2 . 17 ( t , J ) 6 . 7 Hz , 2H ) , 2 . 15 ( s , 6H ) , 1 . 85 ( quin , J ) 6 . 9 Hz , 2H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 5 , 150 . 5 , 146 . 5 , 144 . 1 , 138 . 1 , 132 . 3 , 127 . 2 , 124 . 9 , 122 . 3 , 121 . 0 , 120 . 7 , 118 . 5 , 114 . 1 , 110 . 6 , 108 . 3 , 97 . 9 , 58 . 0 , 55 . 3 , 44 . 9 , 43 . 3 , 40 . 2 , 26 . 8 , 11 . 0 . 2 - Cyano - N - cyclohexyl - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2 - meth - yl - 1 H - indol - 3 - yl ] - acrylamide ( 29 ) . Compound 29 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylami - nopropyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - cyclo - hexyl - 2 - cyanoacetamide ( 18c ) to give , after recrystallization from ethanol , a light - yellow solid ( 67 % ) ; mp 163 - 165 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 40 ( s , 1H ) , 8 . 16 ( br , 1H ) , 8 . 02 ( d , J ) 7 . 4 Hz , 1H ) , 7 . 67 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 26 ( m , 2H ) , 4 . 28 ( t , J ) 7 . 0 Hz , 2H ) , 3 . 74 ( m , 1H ) , 2 . 72 ( s , 3H ) , 2 . 20 ( t , J ) 7 . 0 Hz , 2H ) , 2 . 08 ( s , 6H ) , 1 . 90 ( m , 2H ) , 1 . 82 ( quin , J ) 7 . 0 Hz , 2H ) , 1 . 32 ( m , 2H ) , 1 . 20 - 1 . 15 ( m , 4H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 2 , 145 . 3 , 144 . 0 , 136 . 1 , 125 . 1 , 121 . 9 , 120 . 8 , 120 . 2 , 118 . 5 , 111 . 0 , 107 . 1 , 97 . 2 , 55 . 4 , 48 . 5 , 44 . 5 , 40 . 2 , 31 . 0 , 26 . 5 , 25 . 0 , 24 . 5 , 23 . 8 , 10 . 0 . 2 - Cyano - N - ethyl - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 30 ) . Compound 30 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - ( dimethylamino ) - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - ethyl - 2 - cyanoacetamide ( 18d ) to give , after recrystallization from ethanol , a yellow solid ( 57 % ) ; mp 136 - 138 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 34 ( s , 1H ) , 8 . 07 ( br , 1H ) , 7 . 96 ( d , J ) 7 . 1 Hz , 1H ) , 7 . 55 ( d , J ) 7 . 1 Hz , 1H ) , 7 . 23 ( m , 2H ) , 4 . 28 ( t , J ) 6 . 3 Hz , 2H ) , 3 . 20 ( q , J ) 6 . 2 Hz , 2H ) , 2 . 66 ( s , 3H ) , 2 . 21 ( m , 2H ) , 2 . 10 ( s , 6H ) , 1 . 82 ( t , J ) 6 . 0 Hz , 2H ) , 1 . 01 ( t , J ) 7 . 2 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 0 , 145 . 1 , 144 . 1 , 136 . 7 , 124 . 3 , 122 . 0 , 119 . 9 , 119 . 1 , 118 . 2 , 110 . 5 , 107 . 2 , 98 . 5 , 56 . 0 , 44 . 4 , 39 . 9 , 28 . 0 , 22 . 1 , 11 . 1 . 2 - Cyano - N - propyl - 3 - [ 1 - ( 3 - dimethylaminopropy ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 31 ) . Compound 31 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylamino - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - propyl - 2 - cyanoacetamide ( 18e ) to give , after recrystallization from ethanol , a yellow solid ( 78 % ) ; mp 142 - 144 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 33 ( s , 1H ) , 8 . 07 ( br , 1H ) , 7 . 96 ( d , J ) 7 . 2 Hz , 1H ) , 7 . 57 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 22 ( m , 2H ) , 4 . 24 ( t , J ) 6 . 1 Hz , 2H ) , 3 . 19 ( q , J ) 6 . 0 Hz , 2H ) , 2 . 56 ( s , 3H ) , 2 . 20 ( m , 2H ) , 2 . 12 ( s , 6H ) , 1 . 83 ( t , J ) 6 . 0 Hz ; 2H ) , 1 . 53 ( q , J ) 7 . 1 Hz , 2H ) , 0 . 88 ( t , J ) 7 . 2 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 1 , 145 . 2 , 144 . 2 , 136 . 9 , 124 . 4 , 122 . 2 , 121 . 1 , 120 . 9 , 118 . 4 , 110 . 5 , 107 . 2 , 98 . 9 , 56 . 0 , 44 . 9 , 40 . 1 , 28 . 3 , 22 . 3 , 11 . 3 . 2 - Cyano - N - butyl - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 32 ) . Compound 32 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylamino - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - butyl - 2 - cyanoacetamide ( 18f ) to give , after recrystallization from ethanol , a yellow solid ( 75 % ) ; mp 124 - 126 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 32 ( s , 1H ) , 8 . 05 ( br , 1H ) , 7 . 95 ( d , J ) 7 . 4 Hz , 1H ) , 7 . 57 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 25 ( m , 1H ) , 4 . 26 ( t , J ) 6 . 4 Hz , 2H ) , 3 . 23 ( q , J ) 5 . 9 Hz , 2H ) , 2 . 57 ( s , 3H ) , 2 . 20 ( m , 2H ) , 2 . 13 ( s , 6H ) , 1 . 83 ( t , J ) 6 . 2 Hz , 2H ) , 1 . 49 ( quin , J ) 7 . 14 Hz , 2H ) , 1 . 32 ( q , J ) 7 . 3 Hz , 2H ) , 0 . 90 ( t , J ) 7 . 1 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 2 , 145 . 3 , 144 . 2 , 136 . 8 , 124 . 5 , 122 . 3 , 121 . 1 , 120 . 9 , 118 . 4 , 110 . 4 , 107 . 5 , 98 . 8 , 55 . 6 , 44 . 95 , 41 . 22 , 41 . 0 , 31 . 13 , 26 . 9 , 19 . 5 , 13 . 6 , 11 . 3 . 2 - Cyano - N - hexyl - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 33 ) . Compound 33 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylamino - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - hexyl - 2 - cyanoacetamide ( 18g ) to give , after recrystallization from ethanol , a yellow solid ( 46 % ) ; mp 100 - 102 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 35 ( s , 1H ) , 8 . 10 ( br , 1H ) , 7 . 98 ( d , J ) 7 . 1 Hz , 1H ) , 7 . 58 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 21 ( m , 2H ) , 4 . 25 ( t , J ) 6 . 2 Hz , 2H ) , 3 . 22 ( q , J ) 7 . 1 Hz , 2H ) , 2 . 58 ( s , 3H ) 2 . 20 ( t , J ) 6 . 6 Hz , 2H ) , 2 . 10 ( s , 6H ) , 1 . 85 ( quin , J ) 6 . 9 Hz , 2H ) 1 . 52 ( quin , J ) 7 . 3 Hz , 2H ) , 1 . 27 ( m , 6H ) , 0 . 89 ( t , J ) 6 . 4 Hz , 2H ) . 13 C NMR ( DMSO - d 6 ) δ 164 . 4 , 147 . 5 , 146 . 3 , 138 . 0 , 127 . 5 , 124 . 1 , 123 . 1 , 121 . 7 , 119 . 5 , 112 . 2 , 108 . 4 , 98 . 6 , 56 . 3 , 45 . 0 , 41 . 5 , 32 . 0 , 28 . 5 , 27 . 8 , 26 . 8 , 26 . 0 , 22 . 9 , 14 . 1 , 11 . 2 , 9 . 7 . 2 - Cyano - N - octyl - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 34 - 1 ) . Compound 34 - 1 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylamino - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - octyl - 2 - cyanoacetamide ( 18h ) to give , after recrystallization from ethanol , a yellow solid ( 52 % ) ; mp 99 - 101 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 32 ( s , 1H ) , 8 . 05 ( br , 1H ) , 8 . 01 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 55 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 22 ( m , 2H ) , 4 . 10 ( t , J ) 6 . 3 Hz , 2H ) , 3 . 81 ( s , 2H ) , 3 . 29 ( q , J ) 6 . 3 Hz , 2H ) , 2 . 31 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 20 ( s , 6H ) , 1 . 85 ( quin , J ) 6 . 5 Hz , 2H ) 1 . 50 ( quin , J ) 6 . 5 Hz , 2H ) 1 . 25 ( m , 12H ) , 0 . 80 ( t , J ) 6 . 3 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 163 . 4 , 146 . 2 , 145 . 1 , 137 . 4 , 126 . 3 , 123 . 4 , 122 . 4 , 121 . 9 , 119 . 7 , 112 . 5 , 108 . 4 , 98 . 2 , 56 . 1 , 45 . 7 , 40 . 6 , 32 . 2 , 28 . 9 , 28 . 6 , 26 . 9 , 26 . 0 25 . 7 , 25 . 3 , 22 . 5 , 13 . 5 , 10 . 5 . 2 - Cyano - N - octyl - 3 - ( 1 - ( 3 - dimethylaminopropyl ) - 1 H - indol - 3 - yl ) - acrylamide ( 34 - 2 ) . Compound 34 - 2 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylaminopropyl ) - 1 H - indole - 3 - carbaldehyde and N - octyl - 2 - cyanoacetamide ( 18h ) to give , after recrystallization from ethanol , a yellow solid ( 67 % ) ; mp 105 - 106 ° C . 1 H NMR ( CDCl 3 ) δ 8 . 64 ( s , 1H ) , 8 . 40 ( s , 1H ) , 7 . 85 ( dd , J ) 6 . 8 , 2 . 1 Hz , 1H ) , 7 . 44 ( dd , J ) 7 . 1 , 1 . 6 Hz , 1H ) , 7 . 37 - 7 . 23 ( m , 2H ) , 6 . 19 ( t , J ) 5 . 4 Hz , 1H ) , 4 . 30 ( t , J ) 6 . 8 Hz , 2H ) , 3 . 41 ( q , J ) 6 . 9 Hz , 2H ) , 2 . 22 ( s , 6H ) , 2 . 07 - 1 . 94 ( m , 2H ) , 1 . 59 ( q , J ) 6 . 96 Hz , 2H ) , 1 . 30 ( m , 12H ) , 0 . 87 ( t , J ) 6 . 6 Hz , 3H ) . 13 C NMR ( CDCl 3 ) δ 161 . 3 , 143 . 3 , 135 . 3 , 132 . 3 , 127 . 9 , 123 . 0 , 121 . 7 , 119 . 0 , 118 . 3 , 110 . 0 , 109 . 5 , 94 . 6 , 55 . 2 , 44 . 8 , 44 . 4 , 39 . 9 , 31 . 3 , 29 . 1 , 29 . 0 , 28 . 8 , 27 . 1 , 26 . 4 , 22 . 1 , 13 . 6 . 2 - Cyano - N - decyl - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 35 ) . Compound 35 was prepared in a similar manner to the synthesis of 19 from 1 - ( 2 - dimethylaminoet - hyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 12 ) and N - decyl - 2 - cy - anoacetamide to give , after recrystallization from ethyl acetate , a yellow solid ( 70 % ) ; mp 95 - 97 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 19 ( s , 1H ) , 7 . 93 ( br , 1H ) , 7 . 85 ( d , J ) 7 . 0 Hz , 1H ) , 7 . 44 ( d , J ) 6 . 9 Hz , 1H ) , 7 . 10 ( m , 2H ) , 4 . 32 ( t , J ) 6 . 9 Hz , 2H ) , 3 . 30 ( q , J ) 6 . 9 Hz , 2H ) , 2 . 73 ( s , 3H ) , 2 . 65 ( t , J ) 6 . 6 Hz , 2H ) , 2 . 10 ( s , 6H ) , 1 . 52 ( quin , J ) 6 . 8 Hz , 2H ) , 1 . 25 ( m , 14H ) , 0 . 85 ( t , J ) 6 . 5 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 165 . 2 , 148 . 6 , 145 . 1 , 138 . 8 , 126 . 5 , 123 . 0 , 121 . 4 , 121 . 0 , 119 . 1 , 110 . 1 , 106 . 3 , 100 . 1 , 58 . 3 , 44 . 7 , 40 . 1 , 39 . 9 , 30 . 1 , 29 . 0 , 28 . 7 , 28 . 6 , 28 . 5 , 26 . 2 , 22 . 1 , 13 . 8 , 10 . 4 . 2 - Cyano - N - dodecyl - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 36 ) . Compound 36 was prepared in a similar manner to the synthesis of 19 from 1 - ( 2 - dimethylaminoet - hyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 12 ) and N - dodecyl - 2 - cyanoacetamide to give , after recrystallization from ethyl acetate , a yellow solid ( 49 % ) ; mp 90 - 92 ° C . 1 H NMR ( CDCl 3 ) δ 8 . 33 ( s , 1H ) , 7 . 99 ( br , 1H ) , 7 . 83 ( d , J ) 6 . 9 Hz , 1H ) , 7 . 40 ( d , J ) 6 . 9 Hz , 1H ) , 7 . 00 ( m , 2H ) , 4 . 30 ( t , J ) 7 . 3 Hz , 2H ) , 3 . 30 ( q , J ) 7 . 3 Hz , 2H ) , 2 . 72 ( s , 3H ) , 2 . 65 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 32 ( s , 6H ) , 1 . 50 ( quin , J ) 7 . 0 Hz , 2H ) , 1 . 31 ( m , 16H ) , 0 . 90 ( t , J ) 6 . 3 Hz , 3H ) . 13 C NMR ( CDCl 3 ) δ 162 . 0 , 145 . 0 , 144 . 0 , 135 . 8 , 124 . 2 , 122 . 1 , 120 . 5 , 119 . 5 , 118 . 6 , 111 . 0 , 106 . 5 , 96 . 5 , 55 . 4 , 43 . 9 , 40 . 3 , 31 . 2 , 29 . 0 , 28 . 7 , 28 . 6 , 26 . 1 , 25 . 5 , 21 . 4 , 13 . 6 , 11 . 2 , 8 . 3 . 2 - Cyano - N - tetradecyl - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 37 ) . Compound 37 was prepared in a similar manner to the synthesis of 19 from 1 - ( 2 - dimethylaminoet - hyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 12 ) and N - tetradecyl - 2 - cyanoacetamide to give , after recrystallization from ethyl acetate , a yellow solid ( 56 % ) ; mp 94 - 96 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 33 ( s , 1H ) , 8 . 07 ( br , 1H ) , 7 . 95 ( d , J ) 7 . 4 Hz , 1H ) , 7 . 55 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 22 ( m , 2H ) , 4 . 25 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 19 ( q , J ) 6 . 3 Hz , 2H ) , 2 . 70 ( s , 3H ) , 2 . 60 ( t , J ) 7 . 2 Hz , 2H ) , 2 . 26 ( s , 6H ) , 1 . 53 ( quin , J ) 6 . 8 Hz , 2H ) , 1 . 30 ( m , 22H ) , 0 . 88 ( t , J ) 6 . 3 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 165 . 4 , 147 . 4 , 146 . 4 , 138 . 8 , 126 . 3 , 123 . 4 , 3770 Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 Hill et al . 122 . 8 , 121 . 3 , 120 . 0 , 112 . 2 , 109 . 3 , 100 . 1 , 58 . 3 , 44 . 1 , 42 . 4 , 37 . 5 , 29 . 8 , 28 . 9 , 28 . 7 , 28 . 6 , 26 . 2 , 25 . 2 , 21 . 1 , 13 . 5 , 8 . 5 . 2 - Cyano - N - decyl - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 38 ) . Compound 38 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylamino - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - decyl - 2 - cyanoacetamide to give , after recrystallization from ethyl acetate , a yellow solid ( 64 % ) ; mp 110 - 112 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 30 ( s , 1H ) , 8 . 02 ( br , 1H ) , 7 . 95 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 60 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 25 ( m , 2H ) , 4 . 26 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 30 ( q , J ) 6 . 5 Hz , 2H ) , 2 . 70 ( s , 3H ) , 2 . 20 ( t , J ) 6 . 5 Hz , 2H ) , 2 . 15 ( s , 6H ) , 1 . 85 ( quin , J ) 6 . 5 Hz , 2H ) , 1 . 55 ( quin , J ) 6 . 6 Hz , 2H ) , 1 . 25 ( m , 14H ) , 0 . 83 ( t , J ) 6 . 4 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 163 . 4 , 146 . 5 , 145 . 1 , 137 . 0 , 125 . 2 , 123 . 1 , 121 . 4 , 120 . 9 , 119 . 2 , 112 . 3 , 108 . 1 , 98 . 5 , 56 . 6 , 45 . 9 , 41 . 6 , 32 . 0 , 30 . 0 , 29 . 0 , 28 . 9 , 28 . 8 , 28 . 6 , 26 . 8 , 26 . 2 , 22 . 0 , 12 . 3 , 11 . 2 . 2 - Cyano - N - dodecyl - 3 - [ 1 - ( 3 - dimethylaminopropyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 39 ) . Compound 39 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylamino - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - dodecyl - 2 - cyanoacetamide to give , after recrystallization from ethyl acetate , a yellow solid ( 64 % ) ; mp 103 - 105 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 32 ( s , 1H ) , 8 . 06 ( br , 1H ) , 7 . 94 ( d , J ) 7 . 3 Hz , 1H ) , 7 . 50 ( d , J ) 7 . 5 Hz , 1H , ) , 7 . 20 ( m , 2H ) , 4 . 20 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 25 ( q , J ) 7 . 2 Hz , 2H , ) , 2 . 71 ( s , 3H ) , 2 . 14 ( t , J ) 6 . 5 Hz , 2H ) , 2 . 13 ( s , 6H ) , 1 . 82 ( quin , J ) 6 . 7 Hz , 2H ) , 1 . 50 ( quin , J ) 6 . 8 Hz , 2H ) , 1 . 26 ( m , 16H ) , 0 . 84 ( t , J ) 6 . 4 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 163 . 2 , 146 . 2 , 143 . 2 , 135 . 3 , 124 . 2 , 123 . 5 , 122 . 2 , 120 . 5 , 119 . 6 , 112 . 4 , 105 . 3 , 98 . 4 , 54 . 2 , 44 . 3 , 42 . 6 , 31 . 6 , 28 . 9 , 28 . 7 , 28 . 6 , 26 . 8 , 26 . 5 , 25 . 3 , 21 . 2 , 13 . 0 , 11 . 4 . 2 - Cyano - N - tetradecyl - 3 - [ 1 - ( 2 - dimethylaminoethyl ) - 2 - methyl - 1 H - indol - 3 - yl ] - acrylamide ( 40 ) . Compound 40 was prepared in a similar manner to the synthesis of 19 from 1 - ( 3 - dimethylamino - propyl ) - 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 13 ) and N - tetradecyl - 2 - cyanoacetamide to give , after recrystallization from ethyl acetate , a yellow solid ( 55 % ) ; mp 99 - 101 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 35 ( s , 1H ) , 8 . 07 ( br , 1H ) , 7 . 93 ( d , J ) 7 . 2 Hz , 1H ) , 7 . 57 ( d , J ) 7 . 5 Hz , 1H ) , 7 . 25 ( m , 2H ) , 4 . 22 ( t , J ) 7 . 2 Hz , 2H ) , 3 . 23 ( q , J ) 6 . 1 Hz , 2H ) , 2 . 70 ( s , 3H ) , 2 . 14 ( t , J ) 6 . 6 Hz , 2H ) , 2 . 05 ( s , 6H ) , 1 . 82 ( quin , J ) 6 . 9 Hz , 2H ) , 1 . 54 ( quin , J ) 6 . 8 Hz , 2H ) , 1 . 30 ( m , 22H ) , 0 . 88 ( t , J ) 6 . 4 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 164 . 4 , 145 . 5 , 144 . 3 , 136 . 2 , 125 . 2 , 122 . 2 , 121 . 1 , 120 . 8 , 118 . 7 , 111 . 5 , 107 . 4 97 . 5 , 55 . 6 , 44 . 9 , 40 . 3 , 31 . 3 , 29 . 2 , 28 . 9 , 28 . 7 , 28 . 6 , 26 . 8 , 26 . 2 , 25 . 3 , 21 . 4 , 13 . 3 , 11 . 2 . 2 - Cyano - N - benzyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 41 ) . Compound 41 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - benzyl - 2 - cyanoacetamide ( 18a ) to give , after recrystallization from ethyl acetate , a yellow solid ( 52 % ) ; mp 238 - 240 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 55 ( t , J ) 5 . 5 Hz , 1H ) , 8 . 40 ( s , 1H ) , 8 . 08 ( d , J ) 7 . 2 Hz , 1H ) , 7 . 75 ( d , J ) 7 . 2 Hz , 1H ) , 7 . 10 - 7 . 00 ( m , 8H ) , 4 . 50 ( d , J ) 5 . 4 Hz , 2H ) , 2 . 62 ( s , 3H , ) . 13 C NMR ( DMSO - d 6 ) δ 163 . 4 , 146 . 0 , 144 . 8 , 140 . 4 , 137 . 8 , 128 . 5 , 127 . 2 , 126 . 5 , 124 . 6 , 123 . 2 , 121 . 0 , 119 . 0 118 . 4 , 111 . 2 , 108 . 3 , 98 . 2 , 58 . 1 , 9 . 9 . 2 - Cyano - N - ( 4 ′ - methoxybenzyl ) - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 42 ) . Compound 42 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - ( 4 ′ - methoxybenzyl ) - 2 - cyanoacetamide ( 18b ) to give , after recrystallization from ethyl acetate , a yellow solid ( 47 % ) ; mp 252 - 254 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 60 ( t , J ) 5 . 4 Hz , 1H ) , 8 . 35 ( s , 1H ) , 7 . 98 ( m , 3H ) , 7 . 53 ( d , J ) 7 . 2 Hz , 1H ) 7 . 20 ( m , 3H ) 4 . 53 ( d , J ) 4 . 1 Hz , 2H ) , 3 . 91 ( s , 3H ) , 2 . 54 ( s , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 163 . 4 , 151 . 5 , 146 . 5 , 145 . 2 , 138 . 2 , 133 . 5 , 126 . 1 , 123 . 2 , 122 . 2 , 121 . 4 , 120 . 4 , 118 . 4 , 115 . 4 , 112 . 4 , 108 . 5 , 98 . 6 , 59 . 2 , 11 . 3 . 2 - Cyano - N - cyclohexyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acryla - mide ( 43 ) . Compound 43 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - cyclohexyl - 2 - cyanoacetamide ( 18c ) to give , after recrystallization from ethanol , a yellow solid ( 86 % ) ; mp 236 - 238 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 30 ( 1H , s ) , 8 . 01 ( 2H , m ) , 7 . 42 ( 2H , d , J ) 6 . 8 Hz ) , 7 . 20 ( 2H , m ) , 3 . 85 ( 1H , m ) , 2 . 67 ( 3H , s ) 1 . 94 ( 2H , m ) , 1 . 54 ( 2H , m ) , 1 . 20 - 1 . 16 ( 4H , m ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 1 , 145 . 3 , 144 . 2 135 . 8 , 124 . 7 , 124 . 2 , 121 . 0 , 120 . 5 , 118 . 5 , 110 . 9 , 106 . 5 , 96 . 8 , 48 . 9 , 31 . 2 , 25 . 6 , 24 . 8 , 24 . 2 , 12 . 1 . 2 - Cyano - N - ethyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 44 ) . Compound 44 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - ethyl - 2 - cyanoacetamide ( 18d ) to give , after recrystallization from ethanol , a yellow solid ( 66 % ) mp 242 - 244 ° C . 1 H NMR ( CDCl 3 ) δ 8 . 35 ( 1H , s ) , 8 . 02 ( 2H , m ) , 7 . 42 ( 2H , d , J ) 6 . 5 Hz ) , 7 . 16 ( 2H , m ) , 3 . 25 ( 2H , quin , J ) 6 . 6 Hz ) , 2 . 54 ( 3H , s ) , 1 . 15 ( 3H , t , J ) 7 . 2 Hz ) . 13 C NMR ( CDCl 3 ) δ 164 . 2 , 146 . 3 , 145 . 1 , 136 . 2 , 125 . 2 , 122 . 2 , 121 . 4 , 120 . 9 , 119 . 9 , 112 . 0 , 103 . 2 , 98 . 3 , 26 . 2 , 14 . 6 , 11 . 5 . 2 - Cyano - N - propyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 45 ) . Compound 45 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - propyl - 2 - cyanoacetamide ( 18e ) to give , after recrystallization from ethanol , a yellow solid ( 75 % ) ; mp 245 - 247 ° C . 1 H NMR ( CDCl 3 ) δ 8 . 30 ( s , 1H ) , 8 . 00 ( m , 2H ) , 7 . 40 ( d , J ) 6 . 8 Hz , 2H ) , 7 . 15 ( m , 2H ) , 3 . 20 ( q , J ) 6 . 5 Hz , 2H ) , 2 . 56 ( s , 3H ) , 1 . 54 ( sex , J ) 7 . 2 Hz , 2H ) , 0 . 87 ( t , J ) 7 . 32 Hz , 3H ) . 13 C NMR ( CDCl 3 ) δ 162 . 4 , 145 . 5 , 144 . 3 , 136 . 1 , 125 . 2 , 122 . 3 , 121 . 1 , 120 . 7 , 118 . 7 , 111 . 6 , 107 . 6 , 97 . 6 , 41 . 33 , 22 . 3 , 12 . 7 , 11 . 20 . 2 - Cyano - N - butyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 46 ) . Compound 46 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - butyl - 2 - cyanoacetamide ( 18f ) to give , after recrystallization from ethanol , a yellow solid ( 78 % ) ; mp 220 - 222 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 38 ( s , 1H ) , 8 . 09 ( m , 2H ) , 7 . 43 ( d , J ) 7 . 1 Hz , 2H ) , 7 . 18 ( m , 2H ) , 3 . 24 ( q , J ) 7 . 0 Hz , 2H ) , 2 . 60 ( s , 3H ) , 1 . 49 ( quin , J ) 7 . 1 Hz , 2H ) , 1 . 35 ( sept , J ) 7 . 7 Hz , 2H ) , 0 . 92 ( t , J ) 7 . 1 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 164 . 5 , 146 . 2 , 145 . 1 , 138 . 2 , 127 . 1 , 124 . 2 , 122 . 3 , 121 . 2 , 119 . 2 , 112 . 6 , 108 . 9 , 99 . 6 , 33 . 2 , 26 . 3 , 20 . 4 , 13 . 1 , 10 . 1 . 2 - Cyano - N - hexyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 47 ) . Compound 47 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - hexyl - 2 - cyanoacetamide ( 18g ) to give , after recrystallization from acetonitrile , a yellow solid ( 64 % ) ; mp 186 - 188 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 32 ( s , 1H ) , 8 . 02 ( m , 2H ) , 7 . 45 ( d , J ) 6 . 9 Hz , 2H ) , 7 . 22 ( m , 2H ) , 3 . 23 ( q , J ) 7 . 1 Hz , 2H ) , 2 . 60 ( s , 3H ) , 1 . 48 ( quin , J ) 7 . 5 Hz , 2H ) , 1 . 29 ( m , 6H ) , 1 . 0 ( t , J ) 6 . 7 Hz , 2H ) . 13 C NMR ( DMSO - d 6 ) δ 163 . 2 , 145 . 2 , 146 . 2 , 137 . 2 , 127 . 4 124 . 2 , 122 . 3 , 121 . 4 , 119 . 6 , 112 . 5 , 106 . 2 , 98 . 2 , 32 . 4 , 29 . 5 , 26 . 8 , 25 . 3 , 22 . 7 , 14 . 2 , 11 . 5 . 2 - Cyano - N - octyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 48 ) . Compound 48 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - octyl - 2 - cyanoacetamide ( 18h ) to give , after recrystallization from aceto - nitrile , a yellow solid ( 52 % ) ; mp 174 - 176 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 28 ( s , 1H ) , 7 . 88 ( m , 2H ) , 7 . 32 ( d , J ) 7 . 2 Hz , 2H ) , 7 . 10 ( m , 2H ) , 3 . 30 ( q , J ) 6 . 8 Hz , 2H ) , 2 . 51 ( s , 3H ) , 1 . 49 ( quin , J ) 6 . 8 Hz , 2H ) , 1 . 24 ( m , 12H ) , 0 . 82 ( t , J ) 6 . 3 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 161 . 4 , 144 . 3 , 143 . 2 , 137 . 1 , 124 . 2 , 121 . 5 , 120 . 1 , 119 . 7 , 117 . 7 , 110 . 5 , 106 . 6 , 98 . 5 , 30 . 2 , 27 . 6 , 27 . 5 , 24 . 2 , 24 . 0 , 23 . 3 , 21 . 0 , 12 . 5 , 9 . 8 . 2 - Cyano - N - decyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 49 ) . Compound 49 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - decyl - 2 - cyanoacetamide to give , after recrystallization from acetonitrile , a yellow solid ( 46 % ) ; mp 166 - 168 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 31 ( s , 1H ) , 7 . 99 ( m , 2H ) , 7 . 38 ( d , J ) 6 . 9 Hz , 2H ) , 7 . 13 ( m , 2H ) , 3 . 25 ( q , J ) 7 . 0 Hz , 2H ) , 2 . 54 ( s , 3H ) , 1 . 52 ( quin , J ) 6 . 9 Hz , 2H ) , 1 . 24 ( m , 14H ) , 0 . 85 ( t , J ) 6 . 5 Hz , 3H ) ; 13 C NMR ( DMSO - d 6 ) δ 165 . 4 , 147 . 4 , 145 . 3 , 138 . 1 , 127 . 2 , 123 . 3 , 120 . 9 , 120 . 2 , 117 . 6 , 110 . 4 , 106 . 2 , 96 . 6 , 31 . 2 , 28 . 2 , 28 . 0 , 27 . 6 , 27 . 5 , 27 . 2 , 26 . 2 , 21 . 1 , 12 . 2 , 10 . 2 . 2 - Cyano - N - dodecyl - 3 - ( 2 - methyl - 1 H - indol - 3yl ) - acrylamide ( 50 ) . Compound 50 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - dodecyl - 2 - cyanoacetamide to give , after recrystallization from acetonitrile , Inhibition of Dynamin Mediated Endocytosis by the Dynoles Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 3771 a yellow solid ( 54 % ) ; mp 165 - 167 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 27 ( s , 1H ) , 7 . 96 ( m , 2H ) , 7 . 35 ( d , J ) 6 . 8 Hz , 2H ) , 7 . 11 ( m , 2H ) , 3 . 24 ( q , J ) 7 . 0 Hz , 2H ) , 2 . 52 ( s , 3H ) , 1 . 48 ( quin , J ) 6 . 6 Hz , 2H ) , 1 . 25 ( m , 16H ) , 0 . 84 ( t , J ) 6 . 0 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 162 . 3 , 145 . 2 , 144 . 0 , 135 . 8 , 125 . 0 , 122 . 1 , 119 . 7 , 119 . 1 , 117 . 7 , 110 . 5 , 105 . 2 , 95 . 2 , 30 . 2 , 27 . 9 , 27 . 7 , 27 . 4 , 26 . 1 , 25 . 3 , 22 . 2 , 12 . 6 , 9 . 9 . 2 - Cyano - N - tetradecyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 51 ) . Compound 51 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 H - indole - 3 - carbaldehyde ( 5 ) and N - tet - radecyl - 2 - cyanoacetamide to give , after recrystallization from acetonitrile , a yellow solid ( 45 % ; mp 160 - 162 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 42 ( s , 1H ) , 8 . 12 ( m , 2H ) , 7 . 55 ( d , J ) 6 . 8 Hz , 2H ) , 7 . 34 ( m , 2H ) , 3 . 45 ( q , J ) 6 . 2 Hz , 2H ) , 2 . 77 ( s , 3H ) , 1 . 67 ( quin , J ) 6 . 9 Hz , 2H ) , 1 . 40 ( m , 22H ) , 1 . 12 ( t , J ) 6 . 4 Hz , 3H ) . 13 C NMR ( DMSO - d 6 ) δ 165 . 6 , 147 . 2 , 145 . 2 , 138 . 2 , 127 . 2 , 124 . 1 , 122 . 1 , 121 . 3 , 119 . 4 , 112 . 5 , 106 . 5 , 98 . 5 , 32 . 4 , 30 . 0 , 29 . 9 , 28 . 9 , 28 . 7 , 26 . 4 , 25 . 6 , 22 . 0 , 14 . 2 , 11 . 1 . 2 - Cyano - N - octyl - 3 - ( 2 - methyl - 1 H - indol - 3 - yl ) - acrylamide ( 52 ) . Compound 52 was prepared in a similar manner to the synthesis of 19 from 2 - methyl - 1 - ( 4 - methylpentyl ) - 1 H - indole - 3 - carbalde - hyde and N - octyl - 2 - cyanoacetamide ( 18h ) to give , after recrys - tallization from ethanol , a yellow solid ( 86 % ) ; mp 236 - 238 ° C . 1 H NMR ( DMSO - d 6 ) δ 8 . 30 ( s , 1H ) , 8 . 01 ( m , 2H ) , 7 . 42 ( d , J ) 6 . 8 Hz , 2H ) , 7 . 20 ( m , 2H ) , 3 . 85 ( m , 1H ) , 2 . 67 ( s , 3H ) 1 . 94 ( m , 2H ) , 1 . 54 ( m , 2H ) , 1 . 20 - 1 . 16 ( m , 4H ) ; 13 C NMR ( DMSO - d 6 ) δ 162 . 1 , 145 . 3 , 144 . 2 135 . 8 , 124 . 7 , 124 . 2 , 121 . 0 , 120 . 5 , 118 . 5 , 110 . 9 , 106 . 5 , 96 . 8 , 48 . 9 , 31 . 2 , 25 . 6 , 24 . 8 , 24 . 2 , 12 . 1 . Acknowledgment . We are grateful for ﬁnancial support from the NH & MRC ( Australia ) , the Children’s Medical Research Institute ( CMRI ) , and the University of Newcastle ( UN ) . This project was also supported by the Epilepsy Research Foundation through the generous support of Finding A Cure For Epilepsy And Seizures ( f . a . c . e . s . ) . Swetha Gaddipati is thanked for technical assistance . T . H . and L . O . gratefully acknowledge scholarship support from UN & CMRI and UN , respectively . References ( 1 ) McLure , S . J . ; Robinson , P . J . Dynamin , endocytosis and intra - cellular signaling . Mol . Membr . Biol . 1996 , 13 , 189 – 215 . ( 2 ) Cousin , M . A . R . ; Robinson , P . J . Mechanisms of synaptic vesicle recycling illuminated by ﬂuorescent dyes . J . Neurochem . 1999 , 73 , 2227 – 2239 . ( 3 ) Brodin , L . L . P . ; Shupliakov , O . Sequential steps in clathrin - mediated synaptic vesicle endocytosis . Curr . Opin . Neurobiol . 2000 , 10 , 312 – 320 . ( 4 ) Hinshaw , J . E . Dynamin and its role in membrane ﬁssion . Annu . Re V . Cell De V . Biol . 2000 , 16 , 483 – 519 . ( 5 ) Cousin , M . A . R . ; Robinson , P . J . The dephosphins : dephospho - rylation by calcineurin triggers synaptic vesicle endocytosis . Trends Neurosci . 2001 , 24 , 659 – 665 . ( 6 ) Mukherjee , S . ; Ghosh , R . N . ; Maxﬁeld , F . R . Endocytosis . Physiol . Re V . 1997 , 77 , 759 – 803 . ( 7 ) Humeau , Y . D . ; Grant , N . J . ; Poulain , B . How botulinum and tetanus neurotoxins block neurotransmitter release . Biochimie 2000 , 82 , 427 – 446 . ( 8 ) Marks , B . ; Stowell , M . H . ; Vallis , Y . ; Mills , I . G . ; Gibson , A . ; Hopkins , C . R . ; McMahon , H . T . GTPase activity of dynamin and resulting conformation change are essential for endocytosis . Nature 2001 , 410 , 231 – 235 . ( 9 ) Hinshaw , J . E . ; Schmind , S . L . Dynamin self - assembles into rings suggesting a mechanism for coated vesicle budding . Nature 1995 , 374 , 190 – 192 . ( 10 ) Stowell , M . H . B . ; Marks , B . ; Wigge , P . ; McMahon , H . T . Nucleotide - dependent conformational changes in dynamin : evidence for a mechanochemical molecular spring . Nat . Cell Biol . 1999 , 1 , 27 – 32 . ( 11 ) Powell , K . A . ; Valvoa , V . A . ; Malladi , C . S . ; Jensen , O . N . ; Larsen , M . R . ; Robinson , P . J . Phosphorylation of dynamin I on Ser - 795 by protein kinase C blocks its association with phospholipids . J . Biol . Chem . 2000 , 275 , 11610 – 11617 . ( 12 ) Anggono , V . ; Smillie , K . J . ; Graham , M . E . ; Valova , V . A . ; Cousin , M . A . ; Robinson , P . J . Syndapin I is the phosphorylation - regulated dynamin I partner in synaptic vesicle endocytosis . Nat . Neurosci . 2006 , 9 , 752 – 760 . ( 13 ) Hilliard , L . M . ; Osicka , T . M . ; Robinson , P . J . ; Nikolic - Paterson , D . J . ; Comper , W . D . Characterisation of the urinary degradation pathway in the isolated perfused rat kidney . J . Lab . Clin . Med . 2006 , 147 , 36 – 44 . ( 14 ) Newton , A . J . ; Kirchhausen , T . ; Murthy , V . N . Inhibition of dynamin completely blocks compensatory synaptic vesicle endocy - tosis . Proc . Natl . Acad . Sci . U . S . A . 2006 , 103 , 17955 – 17960 . ( 15 ) Boucrot , E . ; Kirchhausen , T . Endosomal recycling controls plasma membrane area during mitosis . Proc . Natl . Acad . Sci . U . S . A . 2007 , 104 , 7939 – 7944 . ( 16 ) Xu , J . ; McNeil , B . ; Wu , W . ; Nees , D . ; Bai , L . ; Wu , L . G . GTP - independent rapid and slow endocytosis at a central synapse . Nat . Neurosci . 2008 , 11 , 45 – 53 . ( 17 ) Macia , E . ; Ehrlich , M . ; Massol , R . ; Boucrot , E . ; Brunner , C . ; Kirchhausen , T . Dynasore , a cell - permeable inhibitor of dynamin . De V . Cell 2006 , 10 , 839 – 850 . ( 18 ) Quan , A . M . ; McGeachie , A . B . ; Keating , D . J . ; van Dam , E . M . ; Rusak , J . ; Chau , N . ; Malladi , C . S . ; Chen , C . ; McCluskey , A . ; Cousin , M . A . ; Robinson , P . J . MiTMAB is a potent dynamin inhibitor that targets the PH domain and blocks two forms of endocytosis . Mol . Pharmacol . 2007 , 72 , 1425 – 1439 . ( 19 ) Hill , T . A . ; Odell , L . R . ; Quan , A . ; Ferguson , G . ; Robinson , P . J . ; McCluskey , A . Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity . Bioorg . Med . Chem . Lett . 2004 , 14 , 3275 – 3278 . ( 20 ) Hill , T . ; Odell , L . R . ; Edwards , J . K . ; Graham , M . E . ; McGeachie , A . B . ; Rusak , J . ; Quan , A . ; Abagyan , R . ; Scott , J . L . ; Robinson , P . J . ; McCluskey , A . Small molecule inhibitors of dynamin I GTPase activity : development of dimeric tyrphostins . J . Med . Chem . 2005 , 48 , 7781 – 7788 . ( 21 ) Zhang , J . ; Lawrance , G . A . ; Chau , N . ; Robinson , P . J . ; McCluskey , A . From Spanish ﬂy to room temperature ionic liquids ( RTILs ) : synthesis , thermal stability and inhibition of dynamin 1 GTPase by a novel class of RTILs . New J . Chem . 2008 , 32 , 28 – 36 . ( 22 ) Toullec , D . ; Pianetti , P . ; Coste , H . ; Bellevergue , P . ; Grand - Perret , T . ; Ajakane , M . ; Baudet , V . ; Boissin , P . ; Boursier , E . ; Loriolle , F . ; Duhamel , L . ; Charon , D . ; Kirilovsky , J . The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C . J . Biol . Chem . 1991 , 266 , 15771 – 15781 . ( 23 ) Hers , I . ; Tavare , J . M . ; Denton , R . M . The protein kinase C inhibitors bisindolylmaleimide I ( GF 109203x ) and IX ( Ro 31 - 8220 ) are potent inhibitors of glycogen synthase kinase - 3 activity . FEBS Lett . 1999 , 460 , 433 – 436 . ( 24 ) Reubold , T . F . ; Eschenburg , S . ; Becker , A . ; Leonard , M . ; Schmid , S . L . ; Vallee , R . B . ; Kull , F . J . ; Manstein , D . J . Crystal structure of the GTPase domain of rat dynamin 1 . Proc . Natl . Acad . Sci . U . S . A . 2005 , 102 , 13093 – 13098 . ( 25 ) Bartlett , S . B . ; Jackson , R . M . ; Kayser , V . ; Kilner , C . ; Leach , A . ; Nelson , N . ; Oledzki , P . R . ; Reid , G . D . ; Warriner , S . L . Comparison of the ATP binding sites of protein kinases using conformationally diverse bisindolylmaleimides . J . Am . Chem . Soc . 2005 , 127 , 11699 – 11708 . ( 26 ) Wood , J . L . ; Stoltz , B . M . ; Dietrich , H . - J . Total synthesis of ( + ) - and ( - ) - K252a . J . Am . Chem . Soc . 1995 , 117 , 10413 – 10414 . ( 27 ) Wood , J . L . ; Stoltz , B . M . ; Dietrich , H . - J . ; Pﬂum , D . A . ; Petsch , D . T . Design and implementation of an efﬁcient synthetic approach to furanosylated indolocarbazoles : total synthesis of ( + ) - and ( - ) - K252a . J . Am . Chem . Soc . 1997 , 119 , 9641 – 9651 . ( 28 ) Trost , B . M . ; Krische , M . J . ; Berl , V . ; Grenzer , E . M . Chemo - , regio - , and enantioselective Pd - catalyzed allylic alkylation of indolocarbazole pro - aglycons . Org . Lett . 2002 , 4 , 2005 – 2008 . ( 29 ) Zhu , G . C . ; Conner , S . E . ; Zhou , X . ; Shih , C . ; Li , T . ; Anderson , B . D . ; Brooks , H . B . ; Campbell , R . M . ; Considine , E . ; Dempsey , J . A . ; Faul , M . M . ; Ogg , C . ; Patel , B . ; Schultz , R . M . ; Spencer , C . D . ; Teicher , B . ; Watkins , S . A . Synthesis , structure - activity relationship , and biological studies of indolocarbazoles as potent cyclin D1 - CDK4 inhibitors . J . Med . Chem . 2003 , 46 , 2027 – 3030 . ( 30 ) Kuethe , J . T . ; Wong , A . ; Davies , I . W . Effective strategy for the preparation of indolocarbazole aglycons and glycosides : Total synthesis of tjipanazoles B , D , E , and I . Org . Lett . 2003 , 5 , 3721 – 3723 . ( 31 ) McCluskey , A . ; Robinson , P . J . ; Hill , T . ; Scott , J . L . ; Edwards , J . K . Green chemistry approaches to the Knoevenagel condensation : comparison of ethanol , water and solvent free ( dry grind ) ap - proaches . Tetrahedron Lett . 2002 , 43 , 3117 – 3120 . ( 32 ) Correa , W . H . E . ; Edwards , J . K . ; McCluskey , A . ; McKinnon , I . ; Scott , J . L . A thermodynamic investigation of solvent - free reactions . Green Chem . 2003 , 5 , 30 – 33 . ( 33 ) Hill , T . A . ; Sakoff , J . A . ; Robinson , P . J . ; McCluskey , A . Parallel solution - phase synthesis of targeted tyrphostin libraries with anticancer activity . Aus . J . Chem . 2005 , 58 , 94 – 103 . 3772 Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 Hill et al . ( 34 ) Calculated using the New and impro V ed ClogP Calculator from Chemaxon http : / / www . chemaxon . com ( home page ) ; http : / / intro . bio . umb . edu / 111 - 112 / OLLM / 111F98 / newclogp . html ( Applet page ) . ( 35 ) Lipinski , C . A . ; Lombardo , F . ; Dominy , B . W . ; Feeney , P . J . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings . Ad V . Drug Deli V ery Re V . 1997 , 23 , 3 – 25 . ( 36 ) Dihedral angles were measured in Spartan 06 version 1 . 0 . 4 ( for Macintosh ) . Wavefunction Inc . , Irvine , CA , ( www . wavefun . com ) , based on 6 - 31 * * energy minimized structures . ( 37 ) Sheff , D . ; Pelletier , L . ; O’Connell , C . B . ; Warren , G . ; Mellman , I . Transferrin receptor recycling in the absence of perinuclear recycling endosomes . J . Cell Biol . 2002 , 156 , 797 – 804 . ( 38 ) Gaborik , Z . ; Hunyady , L . Intracellular trafﬁcking of hormone receptors . Trends Endocrinol . Metab . 2004 , 15 , 286 – 293 . ( 39 ) Robinson , P . J . ; Sontag , J . - M . ; Liu , J . P . ; Fykse , E . M . ; Slaughter , C . ; McMahon , H . T . ; Su¨dhof , T . C . Dynamin GTPase regulated by protein kinase C phosphorylation in nerve terminals . Nature 1993 , 365 , 163 – 166 . ( 40 ) Quan , A . ; Robinson , P . J . Rapid puriﬁcation of native dynamin I and colorimetric GTPase assay . Methods Enzymol . 2005 , 404 ( Chapter 49 ) , 556 – 569 . ( 41 ) van der Bliek , A . M . ; Redelmeier , T . E . ; Damke , H . ; Tisdale , E . J . ; Meyerowitz , E . M . ; Schmid , S . L . Mutations in human dynamin block an intermediate stage in coated vesicle formation . J . Cell Biol . 1993 , 122 , 553 – 563 . JM900036M Inhibition of Dynamin Mediated Endocytosis by the Dynoles Journal of Medicinal Chemistry , 2009 , Vol . 52 , No . 12 3773